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When unfolded proteins accumulate in the endoplasmic reticulum (ER), the 
unfolded protein response (UPR) increases ER protein folding capacity to 
restore protein folding homeostasis. Unfolded proteins activate UPR signalling 
across the ER membrane to the nucleus by promoting oligomerisation of 
IRE1, a conserved transmembrane ER stress receptor. Despite significant 
research, the mechanism of coupling ER stress to IRE1 oligomerisation and 
activation has remained contested. 
There are two proposed mechanisms by which IRE1 may sense accumulating 
unfolded proteins. In the direct binding mechanism, unfolded proteins are able 
to bind directly to IRE1 to drive its oligomerisation. In the chaperone inhibition 
mechanism, unfolded proteins compete for the repressive BiP bound to IRE1 
leaving IRE1 free to oligomerise. Currently, these two mechanisms 
respectively lack compelling in vivo and in vitro evidence required to assess 
their validity. 
The work presented here first describes in vivo experiments that identify a role 
of the ER co-chaperone ERdj4 as an IRE1 repressor that promotes a complex 
between the luminal Hsp70 BiP and the luminal stress-sensing domain of 
IRE1α (IRE1LD). This is then built on by a series of in vitro experiments 
showing that ERdj4 catalyses formation of a repressive BiP-IRE1LD complex 
and that this complex can be disrupted by the presence of competing unfolded 
protein substrates to restore IRE1LD to its default, dimeric, and active state. 
The identification of ERdj4 and the in vitro reconstitution of chaperone 
inhibition establish BiP and its J-domain co-chaperones as key regulators of 
the UPR. 
This thesis also utilises the power of Cas9-CRISPR technology to introduce 
specific mutations into the endogenous IRE1α locus and to screen for de-
repressing IRE1α mutations. Via this methodology, two predicted unstructured 
regions of IRE1 are found to be important for IRE1 repression. Finally, this 
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CD Cytosolic Domain 
CHO Chinese Hamster Ovary 
CLD Core Luminal Domain 
CPY Carboxypeptidase 
ER Endoplasmic Reticulum 
ERdj ER-localised J-protein 
FACS Fluorescence Activated Cell Sorting 
FRET Föster Resonance Energy Transfer 
HDR Homology Directed Repair 
IB Immunoblot 
IP Immunoprecipitation 
IRE1 Inositol Requiring Enzyme 1 
LD Luminal Domain 
MPZ Myelin Protein Zero 
NBD Nucleotide Binding Domain 
NEF Nucleotide Exchange Factors 
OG Oregon Green fluorophore 
SBD Substrate Binding Domain 
SP Signal Peptide 
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TAM Tetramethylrhodamine fluorophore 
Tg Thapsigargin 
Tm Tunicamycin 
TM  Transmembrane 
UPR Unfolded Protein Response 
WT Wildtype 
XBP1us Unspliced XBP1 












































The unfolded protein response 
The endoplasmic reticulum (ER) is the central hub for the synthesis of 
secretory and transmembrane proteins. Following co-translational insertion 
into the ER lumen, the nascent polypeptides fold into their specific tertiary 
structure. A large proportion of these proteins require aid in order to fold 
correctly, this is provided in the form of chaperone proteins. Under basal 
conditions, the influx of proteins, referred to as the folding load, is balanced 
against the folding capacity of the ER. Perturbations to this balance decrease 
the efficiency of protein folding and can lead to accumulation of unfolded 
(taken in this thesis to include misfolded) proteins, decreased cell function, 
and cell death. This is referred to as ER stress (taken in this thesis to refer to 
protein stress and distinct from lipid stress). Physiological perturbations to the 
balance can come from fluctuations in protein synthesis, e.g. during 
physiological upregulation of antibody or insulin production and secretion, or 
from exposure to harsh environmental conditions, e.g. high temperature. 
Experimentally various small molecules are used to induce the UPR: 
Thapsigargin (Tg) depletes ER calcium by inhibiting the replenishing SERCA 
calcium pumps (Sagara et al., 1991; Wong et al., 1993). Tunicamycin (Tm) 
inhibits the ER glycosylation machinery which is required for the correct 
folding of many proteins (Takatsuk et al., 1975). Dithiothreitol (DTT) perturbs 
the redox environment of the ER and reduces disulfides, which are required 
for the stability of many proteins (Okamura et al., 2000). 
In eukaryotes, the folding load against capacity balance is constantly 
monitored and maintained by signalling pathways whose response to 
increasing levels of unfolded proteins is called the unfolded protein response 
(UPR) (Cox et al., 1997; Kozutsumi et al., 1988). The mammalian UPR 
consists of three signalling branches, each headed by a separate signal 
transducer located in the ER membrane, which monitors the state of the ER 
lumen (Figure 1.01). These three transducers are IRE1, PERK and ATF6, 
each of which output specific transcriptional programmes through the 
respective transcription factors of their signalling pathway: XBP1, ATF4 and 
ATF6-N. These transcription factors upregulate the genes necessary for ER 
synthesis and also increase expression of chaperones (Harding et al., 2003; 
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Sriburi et al., 2004; A. Lee et al., 2005). In addition to these transcriptional 
outputs, IRE1 and PERK reduce the protein folding load by degrading ER-
protein encoding mRNAs and inhibiting global translation respectively. This 
dual pronged attack on decreasing folding load and increasing folding capacity 
aims to restore balance and protein folding homeostasis (reviewed in Walter 
and Ron, 2011).  
A good deal is known about the effector functions of the UPR transducers, the 
physiological significance of ER stress, and the response to it (reviewed in 
Wang and Kaufman, 2016). However, the molecular mechanism(s) by which 
the UPR branches monitor the balance of folding load and capacity of the ER 
remains poorly understood. Studies to understand the sensing mechanism 
have largely focused on the most conserved of the signal transducers, namely 
IRE1, which is conserved in all eukaryotes. 
Figure 1.01 An outline of the UPR in which the balance between the folding load 
and capacity of the ER is monitored by signalling pathways, which act to restore 




IRE1 and its regulation 
The majority of the mechanistic insight into IRE1 regulation has been obtained 
from studies on yIRE1 and mammalian IRE1 isoforms. This is in part due to 
the historical context of IRE1’s discovery and part due to the potential 
relevance of IRE1 in human disease. In this thesis, where important, the 
distinction between yIRE1, and the mammalian isoforms, IRE1α, and IRE1β 
will be made. 
An overview of IRE1 
A series of genetic screens were responsible for the discovery and 
characterisation of yIRE1. yIRE1 first came to light as a protein kinase 
necessary for growth on low inositol media and was proposed to be an 
essential component in regulating inositol synthesis (it was also the first yeast 
transmembrane kinase identified) (Nikawa and Yamashita 1992). 
IRE1 heads the sole UPR branch in yeast and consequently was found to be 
essential for the response and survival of yeast to stress (Cox et al., 1993; 
Mori et al., 1993). Its discovery in mammals was somewhat hampered by the 
low sequence homology of yIRE1 with the mammalian counterparts but it was 
found that mammals harboured two isoforms of IRE1, IRE1α and IRE1β. 
IRE1α is ubiquitously expressed in all tissues whilst expression of IRE1β is 
limited to the gut epithelium (X. Z. Wang et al., 1998; Tirasophon et al., 1998). 
The IRE1 cytosolic domain was seen to have sequence homology to the 
mammalian, oligomerisation-activated RNaseL endoribonuclease/kinase 
protein and lead to the discovery that yIRE1 was directly involved in the 
cytosolic non-conventional splicing mechanism that had been identified as a 
critical step in activating the UPR-essential Hac1 transcription factor in yeast 
(J S Cox and Walter 1996; Sidrauski and Walter 1997). The mammalian Hac1 
orthologue is XBP1 which is similarly spliced by IRE1α/β to promote XBP1 
translation and the conserved XBP1-dependent gene expression program 
(Figure 1.02) (Yoshida et al., 2001; Calfon et al., 2002). IRE1 cleaves cytosolic 
unspliced XBP1 mRNA (XBP1us) at two conserved stem-loop sites and the 
two terminal fragments are then ligated by the tRNA ligase RTCB to form 
spliced XBP1 mRNA (XBP1s) (Lu et al., 2014; Jurkin et al., 2014).  
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This splicing event removes a translational STOP codon from the intron and 
places the second exon in frame with the first allowing the functional XBP1 
transcription factor to be translated.  
The primary output of IRE1 activity is generating the active XBP1 (as seen by 
the similarity in phenotype between IRE1 and XBP1 knockout animals) (Calfon 
et al., 2002; Iwawaki et al., 2010). However, activated IRE1 is also reported to 
activate the JNK signalling cascade via its cytosolic kinase domain and 
degrade ER localised mRNAs via its cytosolic endoribonuclease domain to 
reduce the synthesis of new ER protein (Urano et al., 2000; Hollien and 
Weissman 2006). 
Figure 1.02 A schematic of the cytosolic splicing of XBP1us mRNA as catalysed by 
IRE1. The XBP1us mRNA contains an intron, which is excised by active IRE1, 
allowing the exons to be ligated to form the full coding sequence for the functional 
XBP1 transcription factor. In the absence of splicing, the intron causes a STOP 





As part of its activation mechanism in response to stress, IRE1 undergoes 
luminal domain (LD)-dimerisation-dependent trans-autophosphorylation on 
cytosolic serine residues (i.e. the kinase of one monomer phosphorylates the 
other monomer) (Shamu and Walter 1996).  These cytosolic activation events 
of IRE1 are conserved and well understood, however this is not the case for 
the luminal events of IRE1. There are two main mechanisms by which IRE1 is 
thought to sense increasing levels of unfolded proteins: the chaperone 
inhibition and direct binding mechanisms. In the chaperone inhibition 
mechanism, IRE1 is held inactive by the principal component of the ER folding 
machinery, the BiP chaperone protein (Kar2 in yeast). During stress, 
accumulating unfolded proteins titrate BiP away from IRE1 in order to 
chaperone their folding leaving IRE1 free to dimerise and activate (Figure 
1.03). The mechanism of direct binding, on the other, hand has IRE1’s default 
state to be monomeric and association with unfolded proteins ligands is 
required to stabilise the active form. In the literature, description of the direct 
binding mechanism also tends to focus on the idea that the fully active form of 
IRE1 is an oligomeric structure rather than a mere dimer (Figure 1.04). It is 
important to note that these two mechanisms are not mutually exclusive and 
models of IRE1 regulation have been proposed featuring both of them.  
Before examining the data supporting these models, the IRE1 protein will be 










Figure 1.03 A cartoon of the chaperone-mediated regulation of IRE1. Under basal 
conditions, IRE1 is held inactive by the ER chaperone BiP. During stress, BiP is 
titrated away from IRE1 by accumulating unfolded proteins. This leaves IRE1 free 
to dimerise and activate. 
Figure 1.04 A cartoon of IRE1 regulation via direct binding of unfolded proteins. 
Under basal conditions, IRE1 remains inactive. During stress, accumulating 




The structure of IRE1 
Crystal structures of the yIRE1 and IRE1α LDs exist (Credle et al., 2005; Zhou 
et al., 2006). Despite the lack of sequence homology, the LD structures show 
a very similar core architecture (Figures 1.05-1.061). This structured region of 
IRE1 is referred to as the core luminal domain (CLD)2. 
The IRE1α CLD domain is tethered to the transmembrane helix by a shorter 
stretch of amino acids referred to as the tail (See figure 1.05+1.07 for an 
overview of the IRE1α domain layout). It is predicted that this tail is largely 
unstructured as, unlike the CLD, it is accessible to protease during limited 
proteolysis experiments (Liu et al., 2003). Additionally this is supported by the 
yIRE1 CLD forming larger and more consistent crystals as compared to the 
full yIRE1 LD (Credle et al., 2005). The CLD is sufficient and necessary for 
IRE1α to dimerise both in vivo and in vitro and is therefore crucial to IRE1 
function (Liu et al., 2003; Zhou et al., 2006). Previously the boundaries of the 
CLD had been unintentionally mapped through a tiling deletion screen, which 
identified regions of yIRE1 required for its response to stress. The results from 
this screen split yIRE1 into five regions where regions II and IV are needed for 
response to stress and make up the CLD (See Figure 1.07 bottom for yIRE1 
layout) (Kimata et al., 2004).  
The yIRE1 crystal structure revealed two IRE1 dimer interfaces, interface 1 
and 2 (Figure 1.06+1.08), that, when mutated, impaired the ability of IRE1 to 
respond to stress (D Oikawa et al., 2005; Credle et al., 2005; Aragón et al., 
2009). These interfaces are arranged such that yIRE1 could theoretically form 
oligomers. In contrast to yIRE1, the IRE1α LD crystal structure (Figure 1.05) 
showed only one of the two dimer interfaces (interface 1) mutation of which 
                                            
1 The 2HZ6 and 2BE1 crystal structures have been further refined to assign 
more of the electron density present to the protein sequence and therefore 
differ from the files in the protein database. Richard Mifsud of Randy Read’s 
group carried out the refinement. 
2 The IRE1 CLD is defined by Zhou et al 2006 as consisting of residues 19-
390, however, the IRE1α CLD crystal structure lacks assigned electron density 
for residues 370-390, suggesting that these residues are not so structured. 
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impairs dimerisation, auto-phosphorylation, and XBP1 splicing in response to 
stress (Zhou et al., 2006).  
Multiple crystal structures of the IRE1 CD also exist and there is again a high 
structural similarity between the yIRE1 and IRE1α domains which supports the 
conserved aspects seen for IRE1 activity (reviewed in (K. P. K. Lee et al., 




Figure 1.05 The crystal structure of the human IRE1α core luminal domain (Zhou et 
al., 2006 PDB: 2HZ6 further refined). The dashed line indicates the dimerisation 
interface 1. The cartoon (right) outlines the domain layout of IRE1: LD – Luminal 
domain, CLD – Core luminal domain, TM – Transmembrane domain, CD – 
Cytosolic domain. 
Figure 1.06 View of interface 1 (indicated by the black dashed line) of the crystal 
structure of the yIRE1 core luminal domain (Credle et al., 2005 PDB: 2BE1 further 
refined). The dashed line indicates the dimerisation interface 1. The cartoon (top 
right) depicts how an extended unfolded protein is thought to occupy the proposed 
peptide binding groove which is flanked by helices in both in the crystal structure 
and the cartoon. Bottom right shows a view of the three hydrophobic sidechains at 
the base of the peptide binding groove. These residues are also coloured green in 
the full crystal structure (left).  
Figure 1.07 The annotated domain/region layout of IRE1α (top) and yIRE1 
(bottom). Blue – the core structured luminal domain (CLD), Red – the predicted 
unstructured IRE1 tail region, Green – the ER targeting signal peptide (SP), Yellow 
– the transmembrane domain (TM), Pink – region I unique to yIRE1. Dark red – the 
predicted IRE1α α-helix. Dashed boxes indicate regions of amphipathicity. 
Numbers indicate the amino acid residue numbers of the luminal domain element 
boundaries and the length of the luminal domain elements are scaled according to 













Figure 1.08 View of interface 2 (indicated by the back dashed line) of the crystal 
structure of the yIRE1 luminal domain (Credle et al., 2005 PDB: 2BE1 further 




Direct binding of IRE1 to unfolded proteins 
The direct binding mechanism for IRE1 regulation was first proposed by 
Shamu & Walter 1996, however, it was only upon solving of the crystal yIRE1 
LD crystal structure that this hypothesis was addressed experimentally. 
Scrutiny of the yIRE1 LD crystal structure (Figure 1.06) revealed an apparent 
MHC-I-like peptide-binding groove spanning interface 1 (Credle et al., 2005). 
This led to the hypothesis that unfolded proteins could engage and drive IRE1 
dimerisation and activation through this site.  
This model predicts that the ER proteome has a high abundance of peptides 
of sufficient affinity for IRE1 to drive its activation when they become exposed 
during stress. ER-localised proteins are through this model proposed to have 
a range of peptide sequences that become exposed during stress to drive 
IRE1 activation. Given the sensitivity of IRE1 to stress such peptide 
sequences would need to be abundant in the ER proteome.  
Experimentally, this mode of IRE1 regulation has been explored in both yeast 
and mammals. 
The β sheet base of the yIRE1 peptide-binding groove features exposed 
methionine, phenylalanine, and tyrosine amino acid side chains (M229, F285, 
Y301 : MFY - Figure 1.06) which, when mutated to alanine (individually or 
combined), decrease the ability of IRE1 to signal in response to stress (Credle 
et al., 2005). This is consistent with these residues providing a hydrophobic 
pocket to bind unfolded proteins (which have exposed hydrophobic regions). 
The crystal structure of IRE1α features a similar peptide-binding groove 
structure with the residues equivalent to MFY being K121, Y161, and Y179 
(Zhou et al., 2006). The likelihood of hydrophobic peptides engaging with this 
groove is already decreased given that it seems unlikely that K121 would be 
able to interact with hydrophobic peptides. Unfortunately, it has not yet been 
possible to generate a stable IRE1α peptide-binding groove mutant3, which 
                                            
3 Purified Y161A IRE1α is prone to precipitation and is seen to have a lower 
melting temperature, suggesting the overall protein structure is compromised 




has made it difficult to assess the direct binding model via similar mutational 
analyses as those used for yIRE1.  
If yIRE1 is able to bind unfolded proteins, then it might exhibit chaperone 
properties (so-called holdase activity) and, indeed, presence of yIRE1 in 
citrate synthase or luciferase aggregation assays inhibits aggregation in a 
manner dependent on MFY (Kimata et al., 2007; Daisuke Oikawa et al., 2009; 
Daisuke Oikawa et al., 2012). Furthermore, expression of mutant 
carboxypeptidase (CPY), a model unfolded protein, activates the yeast UPR 
and can be seen to interact with yIRE1 in a manner dependent on MFY (and 
to some extent the integrity of both dimerisation interfaces) (Promlek et al., 
2011; Gardner and Walter 2011).  
To assess the peptide sequence binding preferences of IRE1, peptide arrays 
derived from UPR inducing proteins have been used (Gardner and Walter 
2011; Karagöz et al., 2017). These have identified a general preference of 
IRE1 for basic and hydrophobic amino acids, which is distinct from the binding 
preferences of BiP or Kar2 (Flynn et al., 1991; Blond-Elguindi et al., 1993). 
Incubation with high affinity peptide binding partners shifts IRE1 to higher 
order oligomers (dependent on MFY) and while interface 2 mutants remain 
able to bind these peptides, they no longer shift to higher molecular weight 
species (Gardner and Walter 2011; Karagöz et al., 2017). It is thought that 
peptide binding induces conformational changes in IRE1, allowing it to 
oligomerise. 
The idea that unfolded proteins engage IRE1 is further built on by the 
possibility that region I of yIRE1 may tie in with the peptide-binding groove. It 
is proposed that a cis-interaction of region I and the peptide-binding groove 
maintains yIRE1 in a monomeric state until a sufficiently high affinity peptide 
competes for binding the groove (Mathuranyanon et al., 2015).  
It is surprising that despite considerable effort no luminally localised peptide 
that binds IRE1 with high affinity has been identified. One can assume that 
                                                                                                                             
indications of compromised protein structure for Y161A and Y179A are seen 
in vivo (Kono et al., 2017 and unpublished data). 
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either the occurrences of such peptides are rare or that the measure of affinity 
in vitro has little bearing on the ability of such sequences to activate IRE1 in 
vivo. In either case the physiological relvance of the in vitro experiments 
supporting the direct binding model is questionable. 
IRE1 oligomerisation in response to stress 
Dimerisation is accepted as the minimal event necessary for IRE1 signalling, 
however, further oligomerisation may be important for full IRE1 activity and it 
is often investigated in the context of the direct binding model (though 
oligomerisation may also be required in the chaperone inhibition mechanism). 
Data regarding IRE1 oligomerisation predominantly comes from microscopy 
studies of cells expressing tagged IRE1 variants which reveal stress induced 
IRE1 clusters (Aragón et al., 2009; Li et al., 2010). 
In yeast, IRE1 clustering is dependent on the integrity of both CD and LD 
dimer interfaces (though CD activity is not required), and correlates with 
increased interaction of yIRE1 molecules as assessed by CoIP (Kimata et al., 
2007; Aragón et al., 2009; Promlek et al., 2011; Ishiwata-Kimata et al., 2013; 
van Anken et al., 2014; Halbleib et al., 2017). Disappearance of these clusters 
correlates with attenuation of yIRE1/IRE1α activity following an initial stress 
insult (Kimata et al., 2007; Li et al., 2010; Pincus et al., 2010). 
It is interesting to note that Hac1 RNA also forms clusters in response to 
stress dependent on the presence of a clustering-competent IRE1 (Aragón et 
al., 2009; van Anken et al., 2014). 
Tagged IRE1α is found to form stress induced clusters (Li et al., 2010; 
Daisuke Oikawa et al., 2012; Kitai et al., 2013; Sundaram et al., 2017). In vitro 
IRE1α LD can form higher order oligomers (Chuan Yin Liu et al., 2002) and 
endogenous IRE1α obtained from cells exposed to stress exists in higher 
molecular weight structures than in the absence of stress (Bertolotti et al., 
2000). Though the IRE1α crystal structure shows only interface 1, crosslinking 
and subsequent mass spectrometry analysis has been used to propose the 
existence of a second interface analogous to the yIRE1 interface 2. When the 
residues involved in this hypothetical interface 2 are mutated IRE1α is unable 
to splice XBP1 or form oligomers in response to stress (Karagöz et al., 2017). 
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The idea that yIRE1 LD oligomerisation is important for its activation well 
matches similar in vitro observations for yIRE1 CD (Korennykh et al., 2009; Li 
et al., 2010, Lee et al 2008). This oligomerisation is captured 
crystalographically by the Walter group, however, it is absent from the crystal 
structure solved by the Sicheri group (K. P. K. Lee et al., 2008).  
A caveat of IRE1 clustering is that it (and also IRE1 activity) is very sensitive 
to expression levels. For example, whilst a de-repressed yIRE1 mutant lacking 
regions I and V forms clusters under basal conditions, lowering the expression 
level removes this phenotype (Kimata et al., 2007; Daisuke Oikawa et al., 
2009; Mathuranyanon et al., 2015). Similarly, cluster formation of IRE1α is 
very dependent on expression levels of the protein (and also to the magnitude 
of stress induced) (Sundaram et al., 2017). Furthermore, the geometry of the 
various IRE1 LD and CD interaction interfaces induces a membrane distorting 
helical structure to IRE1 oligomers, which may disfavour their formation at 
endogenous expression levels (Credle et al., 2005; Kimata et al., 2007). I am 
unaware of published experiments showing stress induced IRE1 cluster 
formation at endogenous levels of IRE1 expression and until this is achieved, 
there will always be doubt as to the physiological relevance of clusters. 
Chaperone-mediated inhibition of IRE1 
The UPR field is in agreement that IRE1 (and PERK) exists in complex with 
BiP, which is disrupted in response to a wide range of ER stressors (including 
Tm, Tg, DTT and inositol depletion) (Okamura et al., 2000; Bertolotti et al., 
2000; Liu et al., 2003; Kimata et al., 2003; Kimata et al., 2004; Oikawa et al., 
2007; Oikawa et al., 2009; Ishiwata-Kimata et al., 2013; Rubio et al., 2011; 
Carrara et al., 2015b; Oikawa et al., 2012). Importantly, this correlation 
extends to the endogenous BiP:IREα complex, which decreases in abundance 
during stress and increases during recovery (Bertolotti et al., 2000).  
The contested issue is whether BiP dissociation actually drives IRE1 
activation. One of the more compelling experiments for chaperone-mediated 
inhibition of IRE1 is that, during moderate UPR activation, the yIRE1 still 
bound to Kar2 is under-phosphorylated relative to the unbound yIRE1 
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(Okamura et al., 2000). However, essential follow-up experiments to probe 
this in more detail have not been reported. 
Attempts have been made to characterise the Kar2 binding site on yIRE1 and 
these have all generally identified that the integrity of region V is essential for 
the formation of the stress-sensitive Kar2:yIRE1 complex (Kimata et al., 2004; 
Daisuke Oikawa et al., 2007; Pincus et al., 2010; Ishiwata-Kimata et al., 2013). 
However, a reproducible de-regulation of IRE1 activity is not seen in the 
various yIRE1 region V mutants and only subtle effects on yIRE1 dimerisation 
are observed (Ishiwata-Kimata et al., 2013). Furthermore in all cases the 
region V yIRE1 mutants still increase their activity in response to stress. For 
IRE1α however, region V (i.e. the tail) seems to play a more prominent role for 
repression and also, as seen for yIRE1, facilitates the association with BiP 
(Daisuke Oikawa et al., 2009). 
As well as studies exploring IRE1 regulation through manipulations of IRE1 
itself, some studies instead focus on BiP to probe the mechanism of 
chaperone inhibition. Over-expression and depletion of luminal Kar2 reveal a 
correlation between BiP/Kar2 levels and suppression of UPR branch signalling 
in response to stress (Hardwick et al., 1990; Dorner et al., 1992; Okamura et 
al., 2000; Bertolotti et al., 2000). It has also been found that temperature-
sensitive mutants of Kar2 that remain bound to yIRE1 during stress prevent 
UPR signalling, whilst expression of those that are unable to bind yIRE1 result 
in constitutive UPR signalling (Kimata et al., 2003). These Kar2 mutants also 
display similar binding patterns with substrate, suggesting the Kar2:IRE1 
interaction is a canonical chaperone substrate interaction (Kimata et al., 
2003). This is further supported by BiP SBD alone being sufficient to bind 
IRE1α and that a mutant BiP unable to make high-affinity interactions with 
substrate is associated with less IRE1 compared to WT BiP (Liu et al., 2003).  
However, the nature of the IRE1/PERK interaction with BiP remains somewhat 
contested and has been characterised as a non-canonical interaction by some 
(Todd-Corlett et al., 2007; Sou et al., 2012; Carrara et al., 2015b; Kopp et al., 
2018).  
Unfortunately, because BiP plays a central and varied role in maintaining ER 
proteostasis multiple conclusions can be drawn from in vivo experiments, 
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which mutate or otherwise alter BiP. For example depletion or overexpression 
of BiP is likely to increase or decrease basal levels of unfolded proteins 
respectively and could through this indirectly affect IRE1 activity. Therefore 
these in vivo studies perturbing BiP do not contribute to the understanding of 
IRE1’s regulation. 
The response of IRE1 to lipid stress 
IRE1 is also seen to respond to perturbations in ER membrane lipid 
composition during lipid stress (Volmer et al., 2013; Robblee et al., 2016; 
Halbleib et al., 2017; N. Kono et al., 2017).  
yIRE1 is proposed to respond to such stress by virtue of an amphipathic helix 
(residues 526-542) partially overlapping with the TM, which partially deforms 
the membrane. During lipid stress, changes in membrane composition favour 
the gathering of IRE1 molecules to minimise the otherwise increased 
deformation of the membrane (Halbleib et al., 2017). Despite this proposed 
alternate mode of yIRE1 regulation, lipid stress still correlates with Kar2 
release from yIRE1, though unlike in the response to protein stress, interface 
2 is not required for yIRE1 activity (Ishiwata-Kimata et al., 2013). Whilst an 
analogous TM proximal amphipathic helix exists in IRE1α (Figure 1.07 top), 
mutational analysis reveals that amphipathicity is dispensable for sensing lipid 
stress and instead generic, physical properties of the TM are sufficient for 
response to changes in the ER membrane lipid composition (N. Kono et al., 
2017). Neither yIRE1 nor IRE1α form clusters in response to lipid stress 
showing that IRE1 activity is not dependent on oligomerisation (Promlek et al., 
2011; Kitai et al., 2013). This point still stands even if membrane properties 
during lipid stress are responsible for hindering oligomerisation rather than 
because of differences in the IRE1 activation mechanism (Kitai et al., 2013; 
Cohen et al., 2017).  
The distinct responses of IRE1 to protein and lipid stress also indicate that the 
ER state is similarly distinct in these conditions. In yeast, it can be seen that, 
despite a similar level of yIRE1 activation, Kar2 incorporates into larger 
complexes during protein stress compared to lipid stress reflecting differences 
in the state of proteostasis (Promlek et al., 2011). In mammalian cells, loss of 
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Mdt-15 (a fatty acid synthesis transcription factor) activates IRE1 and PERK, 
and alters the ER membrane lipid composition but does not change the state 
of proteostasis (Hou et al., 2014).  
Given that BiP dissociation from IRE1 is seen in response to both lipid and 
protein stress it suggests that it, unlike cluster formation, plays an essential 
role in IRE1 regulation. 
Regulation of the PERK and ATF6 UPR branches 
The UPR signal transducer PERK has similarities with IRE1 and an 
understanding of PERK regulation may give insight into the regulation of IRE1.  
Despite having low sequence homology the structural homology of IRE1α LD 
and PERK LD is striking (Compare Figure 1.05 and Figure 1.09). Interface 1 is 
present in the PERK crystal structure (in addition to a novel one absent from 
IRE1 crystal structures) (Zhou et al., 2006; Carrara et al., 2015a). Unlike 
yIRE1, structurally PERK tetramers are seen to be ring like structures rather 
than filaments and are important for activation of PERK in response to stress 
(Carrara et al., 2015a). In vitro PERK LD forms oligomers with a (monomer-
dimer) Kd of 0.53 µM (Zhou et al., 2006; M. Carrara et al., 2015). In vivo 
PERK is normally monomeric and, during stress, has been seen to redistribute 
into oligomers (even more so than IRE1α) which are enriched for the active 
phosphorylated PERK form (PERK-P) (Bertolotti et al., 2000).  
The conservation of interface 1 between the evolutionarily distant yIRE1, 
IRE1α, and PERK proteins strongly supports that it is not formed through a 
crystal packing artefact and has an important physiological relevance to these 
proteins. 
Like with IRE1α, an endogenous BiP:PERK complex can be detected, whose 
abundance decreases in response to stress and is destabilised by ATP. This 
complex is also seen to reform post-stress in a manner that correlates well 
with deactivation of PERK-P by dephosphorylation (Bertolotti et al., 2000). 
Furthermore deletions in the equivalent to region V (Figure 1.07) of PERK 
decrease the abundance of BiP:PERK complexes and correlate with 
increased basal auto-phosphorylation of PERK (Ma et al., 2002). 
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Domain swap experiments with IRE1 and the finding that artificial dimerisation 
of PERK LD with an antibody results in CD activation suggests that activation 
of PERK CD is achieved simply by inducing dimerisation (C Y Liu et al., 2000; 
Bertolotti et al., 2000). From this it could be extrapolated that the same holds 
true for IRE1 CD and that dimerisation is sufficient for activation, rather than 
by propagation of a conformational change from the LD via the TM, as seen 
for other dimeric signal transducers, e.g. the insulin receptor (and other 
tyrosine kinase receptors) (L. Ye et al., 2017). 
The activation mechanism of the ATF6 branch is quite different from the 
IRE1/PERK branches. During stress the ATF6 type II membrane protein 
traffics to the Golgi apparatus where site-1 and site-2 proteases cleave the N-
terminal CD to liberate the ATF6-N transcription factor in a mechanism similar 
to regulation of SREBP (sterol regulatory element-binding proteins) (Haze et 
al., 1999; J. Ye et al., 2000). Despite this very different activation mechanism, 
a regulatory role for BiP may still prevail as ATF6 is seen to exist in a 
chaperone-substrate complex with BiP that dissociates in response to stress 
(J. Shen et al., 2005).  
Figure 1.09 The crystal structure of the human PERK luminal domain (Carrara et 
al., 2015a PDB: 4YZS). The black dashed line indicates the dimer interface, which 




The inverse correlation between BiP association and stress for all three 
mammalian UPR branches points towards an evolutionarily conserved 
mechanism which relies on the specialised chaperone activity of BiP to 
monitor the levels of unfolded proteins in the ER. 
However, to investigate chaperone inhibition, both experimental design and 
the interpretation of data from them needs to be informed by a clearer 
understanding of BiP activity and how this is regulated. 
 
Hsp70s and regulation of chaperone activity 
BiP is a member of the Hsp70 protein chaperone family. This family spans all 
kingdoms of life and was initially discovered through their involvement in the 
bacterial heat shock response in which they play a crucial role in preventing 
the aggregation of accumulating misfolded proteins. 
Though mammalian cells express 17 different Hsp70s, BiP is the sole Hsp70 
of the ER and is also the most abundant member of the ER’s chaperone 
constituents (Ghaemmaghami et al., 2003; Daugaard et al., 2007). Hsp70 
number varies considerably between eukaryotes with as few as 7 in 
Schizosaccharomyces Pombe or up to 26 in Orya Sativa, however BiP (or its 
homologues) remains the sole Hsp70 of the ER across eukaryotes (Craig and 
Marszalek 2017). BiP is involved in all facets of proteostasis: in assisting co-
translational translocation of the nascent peptide, chaperoning the folding of 
nascent and misfolded proteins, and targeting terminally misfolded proteins for 
degradation (reviewed in Gething 1999; Dudek et al., 2009; Wang et al., 
2017). Under basal conditions, BiP is present at high concentrations in the ER 
and is strongly transcriptionally upregulated during the UPR (Kozutsumi et al., 
1988; Chang et al., 1989). 
Like other Hsp70s, the BiP protein is comprised of a substrate-binding domain 
(SBD) and a nucleotide-binding domain (NBD) (Figure 1.10, see also the 
related structure of DnaK-ATP PDB:4B9Q Kityk et al., 2012). The SBD 
comprises of a core β-sheet base and an α-helical lid between which BiP 
substrates are bound. The NBD is an ATPase whose nucleotide state couples 
to large conformational changes of the SBD through contacts mediated by the 
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conserved linker region connecting the two domains. In the ATP-bound state 
the SBD exists in the “open” form where the lid makes extensive contacts with 
the NBD rather than covering the SBD β-sheet base (Figure 1.10 top 
BiP:ATP). In this conformation BiP has high kon and koff rates for substrates, 
resulting in an overall low affinity of binding. Hydrolysis of ATP to ADP 
switches the SBD to the high-affinity “closed” state with low kon and koff rates 
(Figure 1.10 bottom). Nucleotide exchange of ADP for ATP is required to 
switch BiP back to the “open” form and complete the chaperone cycle (Swain 
et al., 2007; Bertelsen et al., 2009; Kityk et al., 2012; M. P. Mayer 2013). 
The intrinsic ATPase and nucleotide exchange activities of BiP (and of Hsp70s 
in general) are low and co-chaperones are required to drive these activities in 
a regulated manner for BiP to function as an efficient chaperone (Figure 1.11) 
(Liberek et al., 1991).  
Nucleotide exchange of BiP is regulated by nucleotide exchange factors 
(NEFs) and the mammalian ER has two, Sil1 and Grp170 (reviewed in Behnke 
et al., 2015), and these are important for stimulating the release of BiP from 
substrates.  
On the other side of the BiP chaperone cycle (Figure 1.11), is the hydrolysis of 
ATP, which is stimulated by ER-localised J-domain proteins (ERdjs).  The 
eight ERdj variants in mammalian cells have in common a conserved J-
domain (Figure 1.12), which is responsible for interacting with and stimulating 
BiP’s ATPase activity (reviewed in Kampinga and Craig, 2010; Mayer, 2013).  
All J-domains share the histidine-proline-aspartate (HPD) motif which, from 
structural analyses, is seen to extend into the ATPase site of the NBD in order 
to stimulate ATP hydrolysis (Kityk et al., 2017). The point mutation of the 
histidine of the HPD motif to glutamine (HPD -> QPD) is a highly effective way 
to inactivate the ability of a J-domain to stimulate Hsp70 ATPase activity 
without compromising the fold of the rest of the protein (Kassenbrock and 







Figure 1.10 Top: Crystal structure of the BiP-ATP complex (PDB: 5E84). Bottom: 
NMR structure of the DnaK-ADP complex (PDB: 2KHO). Red – inter-domain linker, 
Light blue – NBD, Blue – α-helical lid of SBD, Dark blue – core of SBD  
Figure 1.11 Cartoon of the BiP chaperone cycle (adapted from Preissler et al., 
2015a). Light pink – BiP nucleotide binding domain, Dark blue – BiP substrate 
binding domain, Purple – nucleotide exchange factor (NEF), Light blue – ER 
localised J protein (ERdj).  
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Whilst stimulation of ATP hydrolysis by BiP is crucial for efficient chaperone 
activity, it is equally important that it occurs in the context of substrate. ERdj 
proteins ensure this is the case by binding to BiP substrate through additional 
protein domains (which differ significantly between the different ERdjs). 
This means that when BiP-ATP makes transient low-affinity interactions with 
its substrates, ERdj proteins are optimally positioned to stimulate ATP 
hydrolysis and switch BiP to its low koff, ADP-bound state coincident with 
substrate occupation of the SBD. The resultant binding of BiP to substrate is 
said to be an ultra-affinity interaction where the binding affinity is higher than 
the equilibrium values observed for either BiP:ATP or BiP:ADP. Such non-
equilibrium ATP hydrolysis-dependent conformational cycles lie at the heart of 
the ability of Hsp70s to function as efficient chaperones (reviewed in 
Misselwitz et al., 1998; Kampinga and Craig 2010; De Los Rios and Barducci 
2014). 
Insight into the importance of J-domain proteins in directing Hsp70 activity 
came from study of the now archetypal bacterial DnaK-DnaJ pair. The DnaK 
Hsp70 holds the heat shock transcription factor (HSF) inactive via a canonical 
chaperone-substrate interaction. During heat stress, misfolded proteins begin 
to accumulate and DnaK is titrated away from HSF allowing it to activate the 
cell’s heat shock transcriptional programme (Abravaya et al., 1992; Tomoyasu 
et al., 1998). The formation of the DnaK:HSF complex is catalysed by the J-
domain containing DnaJ, which independently binds HSF and stimulates the 
ATP hydrolysis by DnaK during its low-affinity association with HSF to switch it 
to a high-affinity interaction (Gamer et al., 1996).  
Figure 1.12 Crystal structure of the J-domain of ERdj5 (PDB: 5AYK). Note in Red the 





This well understood system in bacteria sets a precedent for the ability of a 
chaperone/co-chaperone pair to regulate the activity of a signalling protein and 

























There are two proposed mechanisms by which IRE1 activates in response to 
protein stress. One suggests that the direct binding of unfolded proteins to the 
IRE1 LD induces the activating dimerisation and oligomerisation of IRE1. The 
alternative hypothesis holds that the UPR is organised along principles similar 
to its cytosolic counterpart, the heat shock response, in which IRE1 is held 
inactive by BiP, which is titrated away during stress. 
The correlation between BiP dissociation from and activation of IRE1 is 
undisputed. However, although there is a clear evolutionary precedent for the 
chaperone inhibition model, attributing more than correlation to the 
dissociation event during the UPR is not possible with the current published 
data. Progress in this regard has been hampered by the inability of BiP to be 
mutated without compromising the ER proteostasis environment and the 
absence of an in vitro system reconstituting the in vivo observations. Until 
either of these hindrances is addressed it will be difficult to build an argument 
of causation for the BiP dissociation event. 
On the other hand, the direct binding model is primarily supported by in vitro 
data, which centres on the ability of peptides that bind the groove of IRE1 to 
drive it into oligomeric structures. In vivo work building on the knowledge of 
these peptides has, however, not been forthcoming and therefore the 
physiological relevance of the in vitro observations remains ambiguous and 
decreases the credibility of this model.  
With the advent of new gene-editing technologies and insights from the Hsp70 
regulation field, this PhD aimed to investigate aspects of IRE1 regulation 
mechanisms. This thesis will outline the in vivo data supporting the role of 
ERdj4 facilitating a repressive BiP:IRE1 complex before describing the in vitro 
reconstitution of this system. Following this, mutational analyses probing IRE1 
regulation and experiments directly assessing the binding of IRE1-activating 
peptides to the IRE1 peptide-binding groove will be described. Finally, these 
results will be discussed in context of the literature and used to suggest a 


























Chapter 2: In vivo evidence for IRE1α regulation by ERdj4 
The CHO dual UPR-reporter cell line 
Mammals have three independent signalling pathway branches constituting 
the UPR. This is convenient for studying the regulation of IRE1 as changes in 
its activity can be assessed against the other branches to reveal specific 
branch effects of interest, rather than effects on global ER proteostasis. With 
this in mind, a dual UPR-reporter Chinese hamster ovary (CHO) cell line was 
created. A pre-existing CHO cell line (X. Z. Wang et al., 1998) stably 
expressing a CHOP::GFP reporter, primarily under the control of PERK 
activity (Figure 1.01), was transduced with a retrovirus encoding an 
XBP1s::Turquoise reporter (a modified version of the XBP1s::Venus reporter 
from Iwawaki et al., 2004) which was integrated into the genome. The 
XBP1::Turquoise reporter (Figure 2.01) contains an out-of-frame Turquoise 
CDS which, upon splicing by active IRE1, is moved in frame allowing the 
Turquoise fluorescent protein to be correctly translated. The resultant dual 
UPR-reporter cell line readily responds to various ER stressors (Figure 2.01). 
Several rounds of selection were required to isolate a clone (S21) that stably 
expressed both reporters and is now a useful tool for in vivo studies on the 
UPR (Sekine et al., 2016; N. Kono et al., 2017). The S21 clone was used to 
generate all cell lines elaborated in this thesis and in experiments is referred to 
as WT. This dual UPR-reporter cell line is a useful tool for capturing the 
significant heterogeneity of proteostasis in stressed or transfected cell 
populations by the high-throughput technique of flow cytometry. As will be 
seen, having a fluorescence-based read-out of UPR phenotypes also greatly 






Figure 2.01 A schematic depicting the stably expressed XBP1s::Turquoise 
fluorescent gene reporter used to give a read-out on endogenous IRE1 activity. 
The unspliced mRNA contains a STOP codon upstream of the out-of-frame 
Turquoise fluorescent protein open reading frame (ORF). When the 26 nucleotide 
intron is removed by the active IRE1, the Turquoise ORF is no longer out of frame 
nor has a STOP codon preceding it. The resultant translated product is a fusion 
protein of the XBP1 and Turquoise protein (also see figure 1.02 for an overview of 
endogenous XBP1 regulatory splicing by IRE1). Shown also are dual channel flow 
cytometry plots of the XBP1s::Turquoise and CHOP::GFP gene reporters of 10,000 




ERdj4 selectively represses IRE1α signalling in mammalian cells 
As described in the introduction, BiP is recruited to its substrates by ERdj co-
chaperones. Given that in vivo evidence suggests the proposed repressive 
BiP:IRE1 complex forms through a canonical chaperone-substrate interaction 
it was hypothesised that ERdj proteins may catalyse the formation of this 
complex. Therefore, to examine the potential role of ERdjs in recruiting BiP to 
IRE1 to repress signalling, CRISPR-Cas9 genome editing was used to 
systematically inactivate the genes encoding the eight known ERdjs in S21 
cells, defined by their ER targeting signal peptide and luminal J-domain (Table 
2.01). Clones harbouring frame-shift insertion/deletion mutations in the 
respective ERdjs were isolated and levels of IRE1 and PERK activity under 
non-stress conditions assessed by flow cytometry (Figure 2.02). 
It was seen that deletion of ERdj2 (Sec63) strongly activated both reporters, 
consistent with a role for this co-chaperone in supporting ER proteostasis or in 
repression of both IRE1 and PERK. In contrast, deletion of ERdj4 
preferentially activated the XBP1::Turquoise reporter. The minor activation of 
Name in thesis Other name/s 
ERdj1 Mjt1 and Dnajc1 
ERdj2 Sec63  
ERdj3 HEDJ and Dnajb11 
ERdj4 MDG-1 and Dnajb9 
ERdj5 JPDI and Dnajc10 
ERdj6 p58IPK and Dnajc3 
ERdj7 Dnajc25 
ERdj8 Dnajc16 




CHOP::GFP observed in the ∆ERdj4 cells was completely suppressed by 
treatment with the selective IRE1 inhibitor 4µ8c (Figure 2.03), indicating that it 
arose not from PERK activity but rather from IRE1’s downstream contribution 
to CHOP induction (Figure 1.01) (X. Z. Wang et al., 1998). Together these 
observations suggest that, unlike ∆ERdj2, activation of the IRE1 branch by 
∆ERdj4 is unlikely to reflect solely compromised ER protein folding.  
 
Figure 2.02 XBP1s::Turquoise and CHOP::GFP reporter activity in CHO cells with 
the indicated ER-localised J-protein (ERdj) deleted. Shown is the median 
fluorescence (± SEM) from 20,000 cells, normalised to wildtype (WT). Data for 
figures generated by Maarten Kamphuis and Claudia Rato. 
Figure 2.03 XBP1s::Turquoise and CHOP::GFP activity in CHO cells untreated or 
treated with the IRE1 inhibitor 4µ8C, which blocks IRE1-dependent CHOP 
activation. Fluorescence normalised to WT. (Mean of medians ± SD, n=3, ***p = 
0.0005, repeated measurements one-way ANOVA, Dunnett’s multiple corrections 




ERdj4 is a small 25.5 kDa soluble protein with an N-terminal J-domain and a 
poorly defined C-terminal region involved in protein binding, referred to here 
as the targeting domain (Figure 2.04). To assess whether both the J- and 
targeting domains of ERdj4 were involved in IRE1 repression different ERdj4 
mutants were created and transfected into the ΔERdj4 cells and the 
XBP1s::Turquoise reporter measured by flow cytometry (Figure 2.05-2.07) 
Figure 2.04 A schematic of the domain layout of ERdj4. Green – Signal peptide (SP), 
Light blue – the ERdj4 J-domain, Dark blue – the ERdj4 targeting domain. Numbers 
indicate the amino acid residue numbers of the domain element boundaries and the 
length of the domain elements are scaled according to number of residues. The 
location of the conserved J-domain HPD motif and targeting-domain cysteine residues 
are indicated. 
Figure 2.05 XBP1s::Turquoise signals from cells transfected with empty plasmid or 
with mCherry marked plasmid encoding ERdj4 with a wildtype or inactive J domain 
(ERdj4QPD). Transfected cells gated for moderate mCherry expression levels as shown 
in figure 2.06.   
Figure 2.06 Dual channel flow cytometry plots of the XBP1s::Turquoise reporter and 
mCherry (a transfection marker) in wildtype and ∆ERdj4 cells transiently transfected 
with a mCherry-tagged plasmid encoding no ERdj4 (“empty”), wildtype ERdj4 and 
mutant ERdj4QPD. The red rectangle delineates the gate used to select cells expressing 




Wildtype ERdj4 was able to attenuate IRE1 activity in ∆ERdj4 cells, but the 
H54Q mutant ERdj4 (ERdj4QPD) that lacks J-domain activity, was largely inert 
(Figure 2.05-2.06). Expression of an ER-localised truncated ERdj4 fused to 
mCherry (containing the J-domain, but lacking the targeting domain), failed to 
attenuate IRE1 activity in ∆ERdj4 cells and instead further activated both the 
IRE1 and PERK reporters (Figure 2.07). This feature was absent from the 
QPD J-domain mutant and is consistent with the idea that deregulated J-
domain activity would perturb protein-folding homeostasis in the ER. These 
data show that the integrity of both J- and targeting domains is required for 
IRE1 repression by ERdj4.  
Figure 2.07 XBP1s::Turquoise and CHOP::GFP signals from cells transfected with 
ER-localised mCherry (ER-mCherry, a control) or mCherry tagged full-length ERdj4 
(ERdj4-mCherry), mCherry tagged ERdj4 isolated J-domain (1-90) (J4-mCherry; 
WT and QPD). Transfected cells were gated for moderate mCherry expression as 
in figure 2.05. 
Figure 2.08 Immunoblot of immunoprecipitated endogenous IRE1α after Phos-tag 
SDS-PAGE. Where indicated, cells were treated with dithiothreitol (DTT). Fraction 
of active (phosphorylated) IRE1-P from this representative blot is noted. 
Figure 2.09 XBP1s::Turquoise signals from wildtype or ∆ERdj4 cells. Where 




De-repression of IRE1, as seen by the elevated XBP1s::Turquoise, should be 
accompanied by increased levels of the active phosphorylated IRE1α under 
basal conditions. Indeed phosphorylation of endogenous IRE1α in the 
absence of stress was consistently higher in ∆ERdj4 CHO cells compared to 
the WT parental cells (Figure 2.08). Interestingly the IRE1 in ΔERdj4 cells still 
responded to ER stress as seen when measuring IRE1α phosphorylation 
(Figure 2.08) or levels of XBP1s::Turquoise (Figure 2.09). This indicates that 
other mechanisms of IRE1α regulation persist in the absence of ERdj4.  
The chaperone inhibition model states that IRE1 repression correlates with the 
abundance of a BiP:IRE1LD complex. In keeping with this is was found that the 
amount of BiP recovered in complex with endogenous IRE1α from ∆ERdj4 
cells was reduced by half, relative to the wild-type cells (Figure 2.10).  
In the absence of one of its repressors it would be expected that IRE1α activity 
would be sensitised to ER stress. However, treatment of WT and ΔERdj4 cells 
with a titration of Tm revealed that, though XBP1s::Turquoise levels were 
consistently higher in ΔERdj4 cells, the IRE1 response to Tm was not 
sensitised by the absence of ERdj4. This can be seen by the EC50 values and 
the normalised XBP1s::Turquoise plot (Figure 2.11). This could be explained 
by adaptive transcriptional changes of the cell to keep the sensitivity of IRE1 in 
an optimum window required for efficient proteostasis.  
Figure 2.10 Representative immunoblot of endogenous IRE1α and associated BiP 
recovered from the indicated cell lines by immunoprecipitation of IRE1α. Ratio of 
BiP to IRE1 signal in 6 independent experiments. Mean ± SD, *p = 0.0118 




A similar finding is seen in the bacterial heat shock response where lowering 
levels of DnaK and DnaJ causes elevated HSP levels under basal conditions 
but the system remains equally sensitive to heat shock (Tomoyasu et al., 
1998). An altered response to heat stress only becomes apparent during the 
recovery period in which HSP levels remain elevated rather than decreasing in 
the presence of correct levels of DnaK and DnaJ (Tomoyasu et al., 1998).  
This is particularly interesting when bearing in mind the many yIRE1 region V 
experiments that do not detect a role of Kar2 binding in yIRE1 regulation as 
assessed by yIRE1 activation but do see delayed attenuation (Pincus et al., 
2010; Ishiwata-Kimata et al., 2013; Mathuranyanon et al., 2015). It may well 
turn out that, as in the bacterial system, homeostasis obscures the role of 
Hsp70 regulation during induction of signal transducers. 
The homeostatic nature of the system is also evident from the negative 
feedback loop of IRE1 activation resulting in ERdj4 upregulation, which is able 
to deactivate IRE1. Other feedback mechanisms likely exist to dampen the 
system and it would be interesting to assess the affects loss of ERdj4 has on 








Figure 2.11 Plot of tunicamycin (Tm) concentration-dependent changes in 
XBP1s::Turquoise and CHOP::GFP reporter gene activity in wildtype and ΔERdj4 
cells. Shown are the median fluorescence values (raw or normalised to the 
untreated sample as indicated) obtained from 10,000 cells in experimental 
triplicates and the fit to sigmoidal does-response curve. The bar chart shows the 
Tunicamycin EC50 values for CHOP::GFP and XBP1s::Turquoise reporters in the 
indicated cell lines. 
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ERdj4 promotes association of BiP with the structured core region 
of the IRE1α luminal domain in cells 
To probe further ERdj4’s role in BiP recruitment to IRE1LD, the cytosolic 
effector domain of hIRE1α was replaced with glutathione S-transferase (GST), 
yielding a convenient sensor, comprised of IRE1α’s luminal and 
transmembrane domain (TM) fused to cytosolic GST and uncoupled from 
downstream signalling (Figure 2.12). IRE1LD-GST recovered by glutathione 
affinity chromatography from ∆ERdj4 cells was associated with some BiP. 
However, in ∆ERdj4 cells, co-transfection of IRE1LD-GST with wildtype ERdj4 
increased the recovery of BiP by 2.5-fold compared with co-transfection of 
ERdj4QPD (Figure 2.13). The specificity of ERdj4’s effect on IRE1 was 
assessed using the UPR relevant PERK and ERdj6 proteins. ERdj4 co-
expression did not increase the recovery of BiP in complex with the luminal 
domain of PERK (Figure 2.14). Similarly, ERdj6, another UPR-induced ERdj 
protein (Yan et al., 2002), did not increase recovery of BiP in complex with 
IRE1LD-GST (Figure 2.15). ERdj4 thus has a specific capacity to promote a 
BiP:IRE1LD complex in vivo.  
As described in the introduction, the tail of IRE1α (and the analogous region V 
Figure 2.12 Schema of the IRE1LD-GST protein containing the entire human IRE1α luminal and 
transmembrane domains (residues 19-486) fused to glutathione S-transferase (GST). 
Figure 2.13 Representative immunoblots of IRE1LD-GST and endogenous BiP, recovered by 
glutathione affinity chromatography or in lysate of transfected ΔERdj4 cells. The bar chart shows 
the ratio of BiP to IRE1LD-GST signal from 4 experiments. Mean ± SD. **p = 0.0048, parametric 
ratio paired Student’s t test). 
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of yIRE1) has been shown to be important for BiP binding and involved in the 
repression of IRE1α. The tail may therefore be required for ERdj4-mediated 
formation of the repressive BiP:IRE1LD-GST complex. However, in ∆ERdj4 
cells ERdj4 was still able to increase BiP recovery with IRE1CLD-GST (Figure 
2.16), indicating its ability to act on the CLD alone. The potential role played 
by the IRE1α tail therefore remains unclear.  
BiP has been reported to associate with IRE1LD in a nucleotide-independent 
manner via its NBD rather than, more conventionally, by its SBD (Carrara et 
al., 2015b; Kopp et al., 2018). However, addition of ATP destabilised both the 
BiP:IRE1LD-GST and the endogenous BiP:IRE1 complexes showing that in 
vivo the BiP:IRE1 complex is sensitive to nucleotide (Figure 2.17-2.18). 
Together, these findings indicate that BiP engages the IRE1CLD as a canonical 




















Figure 2.14 As in figure 2.13; compares IRE1LD-GST to PERKLD-GST. R(B/LD) notes 
the ratio of the BiP signal to the GST from the representative experiment shown. 
Figure 2.15 As in figure 2.13; compares ERdj4 to ERdj6. 
Figure 2.16 As in figure 2.13; compares IRE1LD-GST to IRE1CLD-GST. 
Figure 2.17 As in figure 2.13; prior to elution with sample buffer, the indicated 
glutathione sepharose beads were incubated for 5 minutes with 3 mM ATP at room 
temperature. 
Figure 2.18 Immunoblot of endogenous IRE1α and BiP recovered from CHO cells of 
the indicated genotype by immunoprecipitation of IRE1α. Prior to elution with sample 
buffer the indicated protein-A sepharose beads were incubated with ATP (as in figure 




Estimating the monomer-dimer equilibrium of endogenous IRE1α 
(Creating the endogenous Q105C IRE1α) 
To determine whether the ERdj4-promoted BiP:IRE1LD-GST complex 
influenced the IRE1LD monomer-dimer transition that would initiate the UPR, a 
method to measure stress-relevant IRE1LD dimerisation in cells was 
established. The crystal structure of dimeric human IRE1LD reveals a polar 
interaction between the Q105 side chains of opposing protomers (Figure 
2.19). It was hypothesised that presence of a cysteine at position 105 might 
permit the formation of detectable, stress-inducible, disulfide-linked IRE1 
dimers. To assess the validity of this hypothesis, the Q105C mutation was 
introduced into the endogenous IRE1α locus in the dual UPR-reporter cell line. 
This was achieved in a two-step process in which, first, an appropriate guide 
sequence was used to target Cas9 endonuclease to introduce a double strand 
break (DSB) in the IRE1α genomic locus adjacent to the Q105 encoding 
sequence. In the absence of an appropriate DNA repair sequence, the cell 
repairs this DSB with error-prone non-homologous end joining DNA repair 
machinery. Such DNA repair can result in mutations, including frame shift 
mutations, which effectively knock out the expression of a gene. Fluorescence 
activated cell sorting (FACS) was used to isolate an IRE1α knock out clone 
(ΔIRE1) and the gene locus sequenced to verify the presence of a knock out 
mutation. The ΔIRE1 cell line provided a convenient background for the 
second step of creating an endogenous Q105C mutation (Figure 2.20).  
Figure 2.19 Crystal structure of human IRE1LD (PDB 2HZ6) highlighting Q105 




A guide-directed Cas9 was again used to introduce a new DSB close to the 
Q105 encoding sequence in the ΔIRE1 cells. This time, a DNA repair 
sequence encoding either IRE1WT or IRE1Q105C was provided to the cells, 
allowing homology directed recombination (HDR) repair of the locus using the 
DNA repair sequence as a template4. Treatment of these cells with an ER 
stressor revealed the sub-population that had correctly repaired their IRE1α. 
2-deoxyglucose (2DG) was used in these experiments because it is a 
reversible glycosylation inhibitor and a milder ER stressor when compared to 
Tm that increases the viability of cells during FACS and more clearly reveals 
differences in the WT and Q105C IRE1 activities.  
FACS was used to collect repaired clones (Figure 2.21) and a mixed 
population for analysis (Figure 2.22). It was found that IRE1Q105C CHO cells 
retained the ability to mount a UPR (Figure 2.20-2.22). IRE1Q105C is expressed 
at a lower level than wild-type IRE1, possibly because it is less stable in cells. 
This decreased expression level likely accounts for the attenuated induction of 
the IRE1 branch of the UPR in IRE1Q105C cells (Figure 2.20-2.22). Despite its 
lower level of expression, ER stress induction by Tg-mediated luminal calcium 
depletion resulted in the formation of a disulfide in the IRE1Q105C mutant cells 
(Figure 2.23), reflecting the close proximity of the cysteines in the activated 
dimer and providing a readout for stress-relevant IRE1LD dimer formation in 
vivo. Importantly, activation of IRE1Q105C is not dependent on disulfide 
formation for activation, as seen by the ability of the ER stressor DTT to 
stimulate IRE1Q105C phosphorylation (Figure 2.24) whilst simultaneously 
disrupting the oxidising environment required for disulfide bond formation in 
the ER (Figure 2.23). IRE1Q105C activation therefore likely occurs in a similar 
manner as IRE1WT. Evidence of the ability of IRE1Q105C to form Q105C-Q105C 
disulfide bonds, comes from the clear disulfide species seen when a modified 
IRE1LD-GST (with the Q105C mutation) is co-expressed with FLAG tagged full 
length IRE1Q105C (Figure 2.25-2.26). 
                                            
4The Q105C repair template introduced an additional C109S mutation to avoid 










Figure 2.21 Dual channel flow cytometry plots of the XBP1s::Turquoise and 
CHOP::GFP gene reporter signals from representative clones obtained from ΔIRE1 
cells challenged with Wt or Q105C repair templates. 10,000 events were collected 
per condition. 
Figure 2.22 Histogram of XBP1s::Turquoise and CHOP::GFP signals obtained by 
flow cytometry analysis of the indicated cell lines untreated or exposed overnight to 










Figure 2.23 Representative immunoblot of endogenous IRE1α and PERK recovered from the 
indicated cell lines by immunoprecipitation of IRE1α or PERK and resolved by reducing and 
non-reducing SDS-PAGE. ER stress was induced by thapsigargin (Tg) or DTT. Data for 
figure generated by Heather Harding 
Figure 2.24 Reducing Phos-Tag SDS-PAGE of endogenous IRE1α recovered from wildtype 
or IRE1Q105C cells treated in the indicated manner. Fraction of active (phosphorylated) IRE1-P 
from this representative blot is noted. 
Figure 2.25 IRE1LD Q105C-GST and IRE1Q105C-FLAG with Q105C-Q105C disulfide indicated. 
Figure 2.26 Immunoblot of FLAG-IRE1Q105C recovered by glutathione affinity chromatography 
from transfected WT CHO cells. Samples were reduced with DTT or left oxidised to preserve 
disulfide species. Star indicates degraded FLAG-IRE1Q105C species. 
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ERdj4 opposes IRE1α luminal domain dimerisation in cells 
The ability of ERdj4 to catalyse formation of the repressive BiP:IRE1 complex 
should be accompanied by a decrease in IRE1 dimerisation. To this end 
IRE1LD Q105C-GST was used to gauge the effect of ERdj4 on the monomer-
dimer ratio (Figure 2.27). Unlike endogenous IRE1Q105C (Figure 2.23), 
exogenously expressed IRE1LD Q105C-GST is abundant and spontaneously 
forms disulfide-linked IRE1LD Q105C-GST dimers. When co-transfected, wild-
type ERdj4 decreased by 2.5-fold the fraction of disulfide-linked, dimeric 
IRE1LD Q105C-GST. ERdj4QPD had no effect on the monomer-dimer ratio 
highlighting the importance of the J-domain activity (Figure 2.27). 
Immunoprecipitation of endogenous BiP from cells transfected with IRE1LD 
Q105C-GST and ERdj4 variants again reveals the ability of ERdj4 to increase 
the abundance of a nucleotide-sensitive BiP:IRE1 complex in a manner that is 
dependent on a functional J-domain (Figure 2.28). Interestingly, ERdj4 
increases the association of BiP with both IRE1LD Q105C-GST free thiol IRE1 
and disulfide linked IRE1LD Q105C-GST species at a ratio that reflects the 
distribution of the IRE1LD Q105C species in the cells. This suggests that both 
ERjd4 and BiP are able to bind IRE1 monomers and dimers and may provide 

















Figure 2.27 Representative immunoblot of IRE1LD Q105C-GST and BiP recovered 
from ΔERdj4 cells transfected with indicated constructs and resolved by non-
reducing SDS-PAGE. The bar chart shows the ratio of disulfide-bound IRE1LD Q105C-
GST dimer to free thiol in indicated samples. Quantified in 6 independent 
experiments (mean ± SD, n=6, ****p <0.0001, unpaired Student’s t test with 
Welch’s correction). 
Figure 2.28 Immunoblots of IRE1LD Q105C-GST recovered by glutathione affinity 
chromatography or BiP immunoprecipitation and resolved on a non-reducing SDS-
PAGE. Immunoblots of endogenous BiP and expressed ERdj4 variants in lysate of 
transfected ΔERdj4 cells are also shown. The percentage of IRE1LD Q105C-GST 
disulfide linked dimers is noted. Prior to elution with sample buffer, the indicated 




Chapter 2 summary 
The data described here point towards an important role for ERdj4 in vivo in 
repressing IRE1α activity. The previously reported inverse correlation between 
IRE1 activation and levels of the BiP:IRE1 complex holds true in the ΔERdj4 
cells and is consistent with a role for ERdj4 acting as a co-chaperone to load 
BiP onto IRE1 in canonical chaperone-substrate event. The nature of the 
BiP:IRE1 complex is supported by the sensitivity it exhibits to incubation with 
ATP.  
Use of IRE1Q105C allowed the effect of ERdj4 on stress-relevant IRE1 
dimerisation to be monitored and revealed that the repression of activity 
correlated with monomerisation. It is noteworthy that the presence of this 
disulfide in the IRE1 dimer would likely occlude the peptide-binding groove 

















Chapter 3: In vitro evidence for IRE1α regulation by ERdj4 
To investigate the role of ERdj4 directly promoting a repressive BiP:IRE1 
complex it was attempted to reconstitute the system in vitro.  
Purifying a functional ERdj4 
Whilst both IRE1α and BiP had previously been successfully purified from 
bacteria (Zhou et al., 2006; Carrara et al., 2015b; Preissler et al., 2015a), 
ERdj4 has not, and obtaining a purified functional form of the protein proved to 
be challenging (see Table 3.01 for an overview of the various constructs 
trialled). Despite being an ER resident protein, ERdj4 is neither glycosylated 
nor known to be otherwise post-translationally modified, and a standard 
bacterial expression system was therefore chosen for purification. The initial 
ERdj4 constructs, with and without N-terminal solubilising domains, all 
suffered from poor solubility and formed aggregates during the expression and 
purification (Table 3.01 1764, 1763, 1762). 
The targeting domain of ERdj4 is not known to be structured and therefore 
may be prone to aggregation outside of the native ER environment. ERdj4 
with a C-terminal MBP solubilising domain was expressed (GST-ERdj4-MBP) 
and purified, yielding an abundant and soluble protein. Despite this success, 
GST-ERdj4-MBP was very poor at loading BiP onto IRE1, despite displaying 
J-domain activity (as assessed by experiments detailed later). Several 
attempts were made to remove either solubilising domain post-purification of 
GST-ERdj4-MBP in case they inhibited the ability of ERdj4 to engage with 
IRE1. However, these attempts resulted in precipitation of the protein.  
ERdj4 possess two cysteines at its far C-terminus which, when expressed in 
the ER, may be involved in an intra-molecular disulfide bond (Figure 2.04). To 
facilitate the formation of such a potential disulfide, a different bacterial 
expression strain (Origami BDE3) was chosen with an oxidising cytosol to 
permit disulfide formation. Use of a purification strategy aimed at preserving 
disulfide bonds was successful in generating a soluble ERdj4 protein (His-
Sumo-ERdj4ox) able to load BiP onto IRE1, suggesting that a structure 
stabilising disulfide forms in ERdj4. The purified His-Sumo-ERdj4ox contained 
multiple contaminating C-terminal truncations and so the MBP solubilising 
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domain was added to protect the C-terminus from degradation. His-Sumo-
ERdj4-MBPox was however significantly less active than His-Sumo-Erdj4ox. 
Given the potential importance of the targeting domain in facilitating 
interactions with IRE1, a longer flexible linker (LL) was included to separate 
ERdj4 and MBP, thereby reducing steric hindrance. The resultant His-Sumo-
ERdj4-LL-MBPox protein was similarly active as His-Sumo-ERdj4ox but did not 
have the contaminating truncated species. 
From this, it seems that the ERdj4 protein has a structurally important disulfide 
and requires an unhindered targeting domain to make productive interactions 




ERdj4 residues 24-223 Bacterial 
strain 
Soluble? Functional? 
N- tag C- tag 
1764 None None Standard No n/a 
1763 GST None Standard No n/a 
1762 His-Sumo None Standard No n/a 
1772 GST MBP (SL) Standard Yes Very low 
2012 His-Sumo None Origami Yes High 
2104 His-Sumo MBP (SL) Origami Yes Low 




Table 3.01 An outline of the various ERdj4 constructs trialled to generate a 
purified ERdj4 from bacteria. SL-short linker, LL-long linker. 
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ERdj4 promotes association of BiP with the structured core region 
of the IRE1α luminal domain in vitro 
The successfully purified constituents were used to investigate ERdj4 
mediated formation of the BiP:IRE1 complex and the importance of this as a 
regulatory event (Figure 3.01). An IRE1LD lacking endogenous cysteines was 
chemically labelled with biotin on its C-terminus (IRE1LD-bio) via a D443C 
mutation. Formation of a BiP:IRE1LD-bio complex was assessed by recovery 
on immobilised streptavidin (Figure 3.02). It was found that BiP and IRE1LD 
formed a complex only in the presence of ERdj45 and ATP (Figure 3.03, lanes 
2, 4, 9). Like its in vivo counterpart (Figure 2.17-2.18), the isolated BiP:IRE1LD 
complex thus formed was sensitive to disruption by incubation with ATP 
(Figure 3.03, upper panel. The residual BiP eluted with SDS, lower panel, 
reflects incompleteness of the preceding ATP elution, as demonstrated in 
figure 3.04 where a further decrease in BiP signal can be seen going from 
lanes 1 and 2 to lanes 3 and 4 respectively with further ATP elutions). The 
ERdj4QPD mutation and mutations in BiP that interfered with its ATPase activity 
(BiPT229A McCarty & Walker 1991) or substrate binding ability (BiPV461F Laufen 
et al., 1999) greatly enfeebled complex formation (Figure 3.03, lanes 5, 7, 8). 
Association of BiP’s isolated NBD with the IRE1LD was not observed (Figure 
3.05), pointing away from the non-canonical BiP:IRE1 interaction previously 
suggested by Carrara et al., 2015b and Kopp et al., 2018.  
Together the data from figures 3.04 and 3.05 suggest instead that the 
BiP:IRE1 complex is a canonical chaperone-substrate interaction and 
therefore requires the functional integrity of BiP’s SBD and NBD as well as the 




                                            
5 The 37 kDa His-Sumo-ERdj4ox was used for these assays rather than the 77 
kDa His-Sumo-ERdj4-LL-MBPox to allow the ERdj4 protein to be distinguished 




Figure 3.01 Coomassie stain of purified BiP, IRE1LD-bio, and ERdj4 after SDS-
PAGE. 
Figure 3.02 Schema of the experiment shown in figure 3.03. 
Figure 3.03 Coomassie-stained SDS-PAGE gel of biotinylated IRE1LD-bio and BiP 
recovered on a streptavidin matrix from reactions constituted as indicated. 
Concentrations used were 5 µM IRE1LD-bio, 8 µM ERdj4, 30 µM BiP, and 2 mM 
ATP.  Q = ERdj4QPD, T = BiPT229A, V = BiPV461F, J = isolated J-domain of ERdj4. 
Proteins were eluted sequentially with ATP (ATP elution) and SDS sample buffer 
(SDS elution).  
Figure 3.04 Coomassie-stained SDS-PAGE gel of biotinylated IRE1LD-bio and BiP 
recovered on a streptavidin matrix from reactions constituted as indicated. Lanes 1 
and 2 show protein recovered as outlined figure 3.02. The streptavidin matrix of 
samples for lanes 3 and 4 went through one additional ATP elution step prior to 
elution in sample buffer and the proteins eluted in the second ATP elution step 
resolved on the gel. 
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The isolated J-domain of ERdj4 retained some ability to promote a BiP:IRE1LD 
complex (Figure 3.03, lane 6), but was reproducibly weaker than full-length 
ERdj4, attesting to the importance of the C-terminal targeting domain of ERdj4 
in vitro in directing it to load BiP onto IRE1 as also seen in vivo.  
To gauge the stoichiometry of the BiP:IRE1 complex size exclusion 
chromatography analysis was carried out in which the elution of an Oregon 
Green labeled IRE1 (IRE1LD-OG) was monitored alone and in complex with 
BiP (as catalysed by ERdj4). As shown the complex elutes as high molecular 
weight species that exceeds the predicted size of a single BiP molecule bound 
to IRE1LD-OG (Figure 3.06). It is therefore likely that multiple BiP molecules 
engage the IRE1LD via multiple binding sites or as BiP oligomers. An indication 
of stoichiometry can also be gleaned from the Coomassie stained gels, which 
also suggest more than one BiP molecule associates with IRE1LD-bio (Figure 
3.03).  
As shown in vivo, ERdj4 is able to act on the core IRE1CLD alone. The same 
held true for the in vitro system as, in the presence of ATP, ERdj4 could recruit 
BiP to IRE1CLD-bio, indicating that the IRE1LD tail region is not essential for 
ERdj4-dependent complex formation between IRE1 and BiP (Figure 3.07).  
To determine whether ERdj4 and BiP interfere with IRE1LD dimerisation in 
vitro, a non-biotinylated, Tetramethylrhodamine (TAM)-labelled fluorescent 
IRE1LD probe was produced (IRE1LD-TAM) and the effect measured of BiP, 
ERdj4 and ATP on recovery of IRE1LD-TAM in complex with IRE1LD-bio 
(Figure 3.08). Consistent with the high affinity of IRE1LD protomers for each 
other, IRE1LD-TAM formed a stable complex with IRE1LD-bio that was readily 
recovered on immobilised streptavidin. However, introduction of wildtype BiP, 
wildtype ERdj4, and ATP interfered with the IRE1LD dimer whilst forming a 
BiP:IRE1LD-bio complex (Figure 3.09). The defect in the isolated J-domain of 
ERdj4 in loading BiP is better revealed here (lane 10) as it shows the total BiP 
bound to IRE1 through a single sample buffer elution rather than the 
separated ATP and sample buffer elutions.  
To explore the importance of NEF in completing the BiP cycle in the ERdj4-
IRE1 system the mammalian ER localised NEF GRP170 was included in 
reaction mixtures. It was seen that the presence of GRP170 significantly 
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increased the amount of BiP recovered with IRE1LD-bio and further attenuated 
recovery of IRE1LD-TAM (Figure 3.10). This showcases the importance of both 










Figure 3.05 Coomassie-stained SDS-PAGE gel of biotinylated IRE1LD-bio and BiP 
recovered on a streptavidin matrix from reactions constituted as in figure 3.02-3.03, 
with BiP or the nucleotide-binding domain of BiP (NBD) as indicated. Data for figure 
generated by Reuben Saunders. 
Figure 3.06 Fluorescence trace (Ex: 496 nm Em: 524 nm) of IRE1LD-OG elution from a 
Sec3 size-exclusion chromatography column. Reaction mixtures of the indicated 
composition were incubated at 30°C for 20 minutes and clarified at 21,000 g for 5 mins. 
Concentrations used: 0.7 µM IRE1LD-OG, 5 µM ERdj4, 40 µM BiP, 2 mM ATP. 
Figure 3.07 As in figure 3.02-3.03, with IRE1CLD. 
Figure 3.08 Schema of the experiment shown in figure 3.09. 
Figure 3.09 Sequential fluorescence scan and Coomassie-stain of the same SDS-
PAGE gel of proteins recovered on immobilised streptavidin from reactions assembled 
from the indicated components. The IRE1LD-bio-loaded beads were allowed to 
associate with fluorescently labelled IRE1LD-TAM, whose recovery in the pull-down 
reports on the integrity of the IRE1LD dimer.  Concentrations used were 0.5 µM IRE1LD-
TAM, 8 µM ERdj4, 30 µM BiP, and 2 mM ATP. Q=ERdj4QPD, T=BiPT229A, V=BiPV461F, 
J=isolated J-domain of ERdj4. 
Figure 3.10 As in figure 3.08-3.09, with 1 µM GRP170. Quantification of the effect of 
GRP170 on BiP association with IRE1LD-bio bar chart displays mean ± SD, n = 3, *p = 
0.0223 by Student’s paired ratio t test. Quantification of the effect of GRP170 on 
IRE1LD-TAM association with IRE1LD-bio bar chart displays mean ± SD, n = 3, *p = 




ERdj4 opposes IRE1α luminal domain dimerisation in vitro 
Bio-layer interferometry (BLI) was used to dissect ERdj4-mediated BiP 
recruitment to IRE1LD. BLI has some similarities to the well-known surface 
plasmon resonance technique in that the reflection of an incident wavelength 
of light is sensitive to the chemical environment around the reflective surface. 
This sensitivity to chemical environment can be used to monitor protein 
binding events in real-time.  
Using BLI robust binding between immobilised IRE1LD-bio on the BLI sensor 
and ERdj4 in solution could be detected that was not dependent on the 
functional integrity of the J domain or the presence of other factors (Figure 
3.11). The isolated J-domain of ERdj4 was not seen to interact with the 
IRE1LD-bio sensor, implicating the C-terminal domain of ERdj4 in the binding 
event. This observation explains the defect in the J-domain alone in forming a 
BiP:IRE1LD complex, as it has no domain guiding its activity. The 
ERdj4:IRE1LD-bio complex had a very low koff rate that was also exhibited by 
the inverse IRE1LD:ERdj4-bio complex (Figure 3.12). In the absence of ATP, 
the binary complex of IRE1LD-bio and ERdj4 interacted minimally with BiP. Nor 
did the binary complex interact with mutants of BiP (BiPT229A and BiPV461F), 
even in the presence of ATP. However, immersing the sensor loaded with the 
ERdj4:IRE1LD-bio complex into a solution of BiP and ATP gave rise to a highly 
reproducible, transient, positive BLI signal, followed by its decline towards the 
baseline signal of the IRE1LD-bio-loaded BLI sensor (observed before 
formation of the ERdj4:IRE1LD-bio complex; Figure 3.11. green trace). The 
kinetics of this biphasic swing in the BLI signal were increased both by the 
amount of ERdj4 bound to the IRE1LD-bio-loaded BLI sensor and by the 
concentration of BiP (data not shown). This biphasic swing suggested that the 
loading of BiP onto IRE1 was displacing the very same ERdj4 that catalysed 
the event. 
To assess this the protein content of the BLI sensor preceding and following 
its immersion into the solution containing BiP and ATP was analysed and this 
revealed the presence of ERdj4 in the former steady state and its absence 
from the latter (Figure 3.13). These observations are consistent with ERdj4’s 
ability to promote formation of a complex between BiP and IRE1LD through 
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directed ATP hydrolysis, and to maintain this complex by facilitating BiP re-
binding following nucleotide exchange. BiP binding disrupts the otherwise 
stable ERdj4:IRE1LD complex. When present at adequate concentrations, 
ERdj4 re-binding to IRE1LD dynamically maintains the BiP:IRE1LD complex as 
demonstrated by the success in isolating the complex in the pull down system 
(Figure 3.03). However, in the BLI set-up ERdj4 stripped from IRE1LD-bio by 
BiP is too dilute to rebind, allowing the BiP:IRE1LD complex to dissipate 
through nucleotide exchange (last segment of green trace in figure 3.11). 
The ability of ERdj4 and BiP to deplete the dimeric IRE1 population could 
occur through forcible disruption of pre-formed IRE1LD dimers or by retention 
of monomers. To address whether the former mechanism occurred, pre-
formed IRE1LD-bio/IRE1LD-TAM dimers were immobilised on streptavidin and 
confronted with BiP, GRP170, and ATP in the presence or absence of ERdj4 
and monitored for the loss of bound IRE1LD-TAM (Figure 3.14). Dissociated 
IRE1LD-TAM was diluted in the large assay volume, minimising the effect of 
rebinding. ERdj4 accelerated the loss of IRE1LD-TAM (Figure 3.15), indicating 





















Figure 3.11 Bio-layer interferometry (BLI) signal of streptavidin sensors loaded with the 
indicated biotinylated ligand and reacted sequentially with the indicated solution of analyte, 
followed sequentially by the indicated solutions of BiP and ATP. Concentrations used were 
1.5 µM ERdj4, 1 µM BiP, 2 mM ATP. Data for figure generated by Reuben Saunders. 
Figure 3.12 BLI signal from streptavidin sensors pre-loaded with a biotinylated ERdj4 
ligand (or with an irrelevant control biotinylated GADD34 ligand) and reacted with the 
indicated concentration of IRE1LD as an analyte and then transferred to a buffer only 
(wash) solution. Data for figure generated by Reuben Saunders. 
Figure 3.13 Protein recovered from a BLI sensor lacking (lane 1) or containing an IRE1LD-
bio ligand (lanes 2-4). The sensor was incubated with an ERdj4 analyte and then with BiP 
or BiPV461F ± ATP. Data for figure generated by Reuben Saunders. 
Figure 3.14 Schema of the experiment shown in figure 3.15. 
Figure 3.15 Fluorescence scans and Coomassie-stained SDS-PAGE gel of proteins 
recovered on immobilised streptavidin from reactions assembled from the indicated 
components. The IRE1LD-bio-loaded streptavidin beads were pre-associated with IRE1LD-
TAM and then incubated in a solution of BiP, ERdj4, GRP170, and ATP. Bar chart shows 
mean IRE1LD-TAM signal recovered with IRE1LD-bio (± SD) from four independent 
experiments, ∗∗∗p = 0.001 by parametric student’s paired ratio t test. Concentrations used 




To determine if, as already hinted in vivo (Figure 2.28), ERdj4 could recruit 
BiP to dimeric IRE1LD in vitro (a prerequisite for the forceful disruption 
suggested by figure 3.15), IRE1LD Q105C was purified, allowed to form Q105C-
Q105C disulfides, and chemically labelled on lysine residues with biotin 
(indicated by a bio*) to form covalently stabilised biotinylated IRE1LD Q105C-bio* 
dimers. ERdj4 bound IRE1, as seen by the BLI signal (Figure 3.16, initial 
ERdj4 association) and the direct analysis of the protein content of the BLI 
sensor (Figure 3.17, lane 3), and recruited BiP to disulfide-linked dimeric 
biotinylated IRE1LD Q105C (Figure 3.18). If as shown in these experiments 
ERdj4 and BiP are indeed able to bind to and disrupt IRE1 dimers they must 
bind at sites away from the dimer interface (which would be sterically 
inaccessible in the IRE1 dimers). This suggests the existence of an allosteric 
component to BiP-mediated inhibition of IRE1. BiP and ATP were also able to 
remove ERdj4 bound to the biotinylated disulfide-linked dimeric biotinylated 
IRE1LD Q105C, indicating that IRE1 de-dimerisation is not a strict pre-requisite 
for BiP-mediated ERdj4 displacement  (Figure 3.16, signal decay during the 




Figure 3.16 BLI signal of streptavidin sensors loaded with the wildtype biotinylated IRE1LD, or 
covalent dimeric disulfide-linked biotinylated IRE1LD Q105C ligands and reacted with ERdj4, followed 
sequentially by the indicated solutions. Concentrations used were 1.7 µM ERdj4, 6 µM BiP, 2 mM 
ATP.  
Figure 3.17 Coomasie-stained non-reducing SDS-PAGE gel of protein recovered by SDS sample 
buffer elution from the BLI sensors used in figure 3.16. The dotted line indicates the boundary at 
which the image contrast/brightness properties were treated differently to make the image clearer.  
Note: To enable formation of Q105C-disulfide, without interference by other cysteines, both the WT 
IRE1LD and the IRE1LD Q105C ligands were surface biotinylated on exposed lysine residues. This 
coupling chemistry likely accounts for the differences in kinetics of the BLI signal observed in this 
experiment as compared with figure 3.11, in which the IRE1LD ligand was biotinylated on a single C-
terminal cysteine residue (D443C) using maleimide biotin. 
Figure 3.18 Coomassie stained non-reducing SDS-PAGE gel of IRE1 and BiP recovered on a 
streptavidin matrix from reactions constituted as in figure 3.02-3.03, but with IRE1LD-bio* or covalent 




Unfolded protein substrates compete with IRELD for BiP, restoring 
IRE1LD dimers  
To monitor the disruption of IRE1LD dimers in real time, a FRET-based assay 
was developed that reports on the IRE1LD monomer-dimer equilibrium (Figure 
3.19). IRE1LD molecules labelled on a single cysteine introduced at R234 with 
an Oregon Green 488 donor were combined with molecules labelled on a 
single cysteine introduced at S112 with a TAM acceptor. A robust FRET signal 
(predicted by proximity of R234 and S112 in the human IRE1LD dimer crystal 
structure), reflected by the quenching of donor fluorescence, was detected. 
Addition of unlabelled IRE1LD restored donor fluorescence nearly to levels 
observed in absence of acceptor molecules, confirming the role of 
dimerisation in the quenched donor fluorescence (Figure 3.20).  
Extended incubation of donor and acceptor-labelled IRE1LD molecules with 
high concentrations of ADP-bound BiP (in the absence or presence of ERdj4) 
did not disrupt the FRET signal, indicating that IRE1LD is a poor equilibrium 
BiP substrate (Figure 3.20, lower traces). However, addition of BiP, ERdj4, 
and ATP to pre-equilibrated donor/acceptor IRE1LD reversed the FRET such 
that donor fluorescence nearly equalled that observed in the absence of 
acceptor molecules. BiP mutants defective in ATP hydrolysis (BiPT229A) and 
Figure 3.19 A cartoon outlining the FRET system. IRE1LD S112C and IRE1LD R234C 
molecules were labelled with the TAMRA (TAM) and Oregon Green (OG) 
fluorophores to create IRE1LD TAM and IRE1LD OG respectively. When IRE1LD OG exists 
in a dimer with IRE1LD TAM the OG fluorophore transfers its excitation energy to TAM 
via FRET and does not fluoresce. The OG IRE1LD OG not in a dimer with IRE1LD TAM is 
able to fluoresce. This system can therefore provide a readout for changes in the 




substrate binding (BiPV461F) and ERdj4QPD were inert, as was BiPAMP that had 
been inactivated by AMPylation (Preissler et al., 2015a).  
The inability of the isolated J-domain of ERdj4 to drive efficient 
monomerisation reveals the importance of the C-terminal targeting domain of 
ERdj4 in guiding it to load BiP onto relevant sites for inhibiting IRE1 
dimerisation. Addition of the NEF GRP170 significantly increased the rate of 
IRE1LD monomerisation (Figure 3.21) highlighting how co-chaperones work 
together to enhance the efficiency of BiP function. Finally, BiP, ERdj4, and 
ATP also disrupted the FRET observed between donor/acceptor labelled IRE1 
core luminal domain identifying this domain of IRE1 as being sufficient for the 
ERdj4 mediated monomerisation (IRE1CLD, Figure 3.22). 
In vivo the chaperone inhibition model relies on the basic tenet that BiP can be 
competed away from IRE1 by substrate to allow IRE1 dimerisation. This 
should still hold true in vitro and was addressed by introducing a BiP substrate 
(CH1 peptide HTFPAVL) (Marcinowski et al., 2011) into the FRET system 
after monomerisation of IRE1 by ERdj4 and BiP. Alone the substrate weakly 
restored the FRET signal to samples maintained in the monomeric state 
however, including sub-stoichiometric amounts of a second J-protein (devoid 
of IRE1LD-binding activity), alongside the BiP substrate, markedly accelerated 
IRE1 dimerisation (Figure 3.23). These observations suggest that BiP binding 
to a substrate peptide directed by an orthogonal J-protein can indeed compete 
successfully for ERdj4-directed, BiP-mediated IRE1LD monomerisation and 
further supports the BiP:IRE1 complex being a canonical chaperone substrate 
interaction. The transitions between the monomeric “low FRET” and dimeric 
“high FRET” states (Figure 3.23) occur on a 30-60 minute time scale similar to 
that of the dissolution of the BiP:IRE1 complex in stressed cells and its 
reformation in cells recovering from stress (Bertolotti et al., 2000), suggesting 
that IRE1LD, BiP, J-proteins, and a BiP substrate together can recapitulate in a 
simple in vitro assay a key aspect of UPR signalling. 





Chapter 3 summary 
Presented here are a series of experiments showing that in vitro ERdj4 
promotes the formation of a canonical chaperone substrate interaction 
between BiP and the IRE1CLD which leads to monomerisation of the IRE1 
population. The congruancy between these in vitro findings with the in vivo 
data from chapter two contests the idea that in vivo ERdj4 plays an indirect 
role in IRE1 repression and supports the physiological relevance of the in vitro 
observations. Though this in vitro system does lack many elements of the ER 
proteostasis machinery it has the advantage of being tolerant to various 
protein mutants (e.g. those of BiP), which can be used to provide mechanistic 
insight into IRE1 repression. Many of these mutants are difficult to exploit in 
vivo, due to their toxic effects on ER homeostasis, and the absence of a 
functional in vitro reconstitution of the chaperone inhibition model has 


















Figure 3.20 Donor fluorescence as a function of the concentration of competing unlabelled 
IRE1LD equilibrated with a FRET pair (0.2 µM labeled IRE1LD) consisting of an IRE1LD-OG 
donor and IRE1LD-TAM acceptor (blue trace). Also shown are titrations of unlabelled IRE1LD 
into a mock FRET sensor (no IRE1LD-TAM acceptor; red trace) and titration of BiP with 2 mM 
ADP (+/- ERdj4) into the pre-equilibrated FRET pair (green and black traces). Data for figure 
generated by Reuben Saunders. 
Figure 3.21 Time-dependent change in donor fluorescence of the IRE1LD FRET pair 
incubated at t=0 with indicated components. Concentrations used were 0.2 µM FRET IRE1LD, 
30 µM BIP, 2.5 µM ERdj4, 1 µM GRP170, and 2 mM ATP. JERdj4 lacks the C-terminal 
targeting region. BiPAMP is AMPylated BiP. *Reaction set up with a mock FRET sensor 
lacking the IRE1LD-TAM acceptor. Data for figure generated by Reuben Saunders. 
Figure 3.22 As in figure 3.21, but with OG488 and TAM-labeled IRE1CLD. Data for figure 





Figure 3.23 Time-dependent change in donor fluorescence of the IRE1LD FRET pair exposed 
at t=0 to BiP, ERdj4 and ATP (arrow labeled “+ ATP”). Concentrations: 0.2 µM FRET IRE1LD, 
50 µM BIP, 2.5 µM ERdj4, 2 mM ATP. Following disruption of the FRET pair, at t=60, CH1 
peptide and the J-domain of ERdj6 (2.5 µM) were added (arrow labeled “+ competitor”). Data 
for figure generated by Reuben Saunders. 
Figure 3.24 In the unstressed ER (green box) ERdj4 binds IRE1 CLD via its targeting 
domain. ERdj4 stimulates BiP’s ATPase activity to drive BiP binding to IRE1, ejection of 
ERdj4, and formation of a repressive BiP:IRE1 complex with a disrupted dimer interface. 
This complex turns over by nucleotide exchange. Free ERdj4 and BiP recruit the released 
IRE1 (as monomer or dimer) in a kinetically maintained repressive cycle. Accumulating 
unfolded proteins during stress (red box) compete for BiP and/or ERdj4, interrupting the 
cycle of repression. IRE1 monomers are free to dimerise and activate downstream signals. 
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Chapter 4: Screening for de-repressing mutations in IRE1α 
Tiling deletions and random mutagenesis of a gene can be a powerful tool to 
begin understanding the regions and residues required for regulation and 
function of the protein. The former has been employed to understand both 
yIRE1 and IRE1α (Kimata et al., 2004; Daisuke Oikawa et al., 2009).  
A Cas9-CRISPR-mediated mutagenesis screen 
With the advent of Cas9-CRISPR technology, it is now possible to carry out 
this technique at the endogenous locus, even in mammalian cells. As 
previously mentioned, repair of DSBs introduced by the Cas9 endonuclease 
can result in mutation of the DNA sequence and if two DSBs are introduced 
simultaneously, it can lead to larger deletions of the DNA sequence between 
them. By introducing a set of Cas9 guides that target a region of interest into 
cells, a semi random pool of mutants will be created containing small 
deletions, substitutions, and insertions around and between the DSB sites. 
The XBP1s::Turquoise reporter is a convenient tool for selecting rare clones 
that have a de-repressed IRE1 resulting from such a Cas9-CRISPR insult and 
the CHOP::GFP reporter can be used to avoid clones which have a general 
perturbation of ER protein homeostasis. Iterative rounds of FACS can enrich 
this XBP1s::Turquoise high population, allowing isolation of clones for 
genotyping and further analysis (Figure 4.01).  
Mutation of the IRE1α tail 
As described in the introduction, the tail of mammalian IRE1 (Figure 1.07) has 
been identified as being important for regulation of its activity. To explore this 
further, Cas9-CRISPR-mediated mutagenesis of the region was carried out. 
Pools of WT cells were separately transfected with Cas9 and guides to 
introduce mutations across the coding sequence of the tail (Figure 4.02). The 
transfected cells were pooled to create Pop 0. Cells expressing elevated 
levels of XBP1s::Turquoise were collected by FACS to create Pop 1. A second 
round of FACS was used to further enrich for cells expressing elevated levels 
of XBP1s::Turquoise to create Pop 2. As well as selecting for clones with de-
repressing mutations of IRE1, this procedure had the potential to enrich for 
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cells in which the XBP1::Turquoise reporter activity was deregulated 
independently of IRE1 activity. To address this possibility, Pop 2 was treated 
with the IRE1 inhibitor 4µ8c which revealed that about 70% of cells relied on 
IRE1 RNase activity to maintain high XBP1s::Turquoise expression whilst the 
remainder had acquired off pathway features affecting the reporter. 
Appropriate 4µ8c responsive clones from Pop2 were collected by a final round 
of FACS. An RT-PCR XBP1 splicing assay was carried out for one of the 
clones, showing that the endogenous XBP1 mirrored the constitutive splicing 
of the XBP1s::Turquoise reporter due to the de-repressed IRE1 (Figure 4.03).  
Sequence analysis of the isolated clones (Table 4.01) revealed a common 
mutation that resulted in deletion of residues 403-441 of the IRE1α protein. To 
validate that this deletion causes de-repression of IRE1α, a strategy to 
reconstitute the endogenous locus with such a deletion was employed. 
 
Figure 4.01 Cas9 guides (red triangles) can be selected at an even distribution 
across the IRE1 genomic locus encoding the protein’s region of interest. 
Transfection of individual or pairs of guides will result in a series of directed 
mutations (blue and red lines). Cells harbouring rare de-repressing mutations of 
IRE1 (blue) can be selected for by rounds of FACS gating on cells expressing high 
XBP1s::Turquoise and low CHOP::GFP. The resultant clones can be genotyped 
and further analysed. 
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The endogenous IRE1 locus consists of 17 exons spanning ~60 kbp (with the 
luminal domain encoded by exons 2-12). To make mutations via Cas9 and 
HDR, a new repair template with new homology arms needs to be designed 
for each exon. Additionally, if desired mutations span several exons, extra 
steps are required to introduce all sets of mutations.  
To make multiple mutations to the endogenous IRE1 locus, a more convenient 
system was therefore utilised, namely the ΔLD15 system (Figure 4.04)(Kono 
et al., 2017). The ΔLD15 system was created as follows. Appropriate Cas9-
CRISPR guides were used to generate a large 50 kbp deletion between exons 
2-11 in the endogenous IRE1α locus. This IRE1 null cell line (ΔLD15) can be 
reconstituted with IRE1 luminal domain variants using templates flanked by 
the same homology arms each time (Figure 4.05). The sequence of the alleles 
in the null cell line and the repair design are such that only one allele will be 
repaired with the IRE1 variant, meaning copy number is always constant 
between different clones. 
The reconstitution of this locus with an IRE1 harbouring the deletion in the tail 
resulted in a de-repressed phenotype compared to when a WT sequence was 
introduced. This builds confidence in the importance of this region for IRE1 





Figure 4.02 XBP1s::Turquoise and CHOP::GFP signals from the cell populations 
elaborated during the Cas9-CRISPR mutation screen targeting the tail of IRE1α as 
outlined in figure 4.01. Sets of WT cells (panel A) were separately transfected with 
Cas9 and guides and pooled (Pop 0 panel D). Pop0 cells with elevated levels of 
XBP1s::Turquoise were collected by FACS (Pop 1 panel E). A second FACS round 
enriched for cells with elevated reporter levels (Pop 2 panel F). Pop 2 was treated with 
the IRE1 inhibitor 4µ8c to identify undesirable cells with mutations that uncouple 
reporter expression from IRE1 activity (30% of Pop 2 panel G). Panels B+C show the 
efficacy of 4µ8c. 4µ8c responsive clones from Pop 2 were collected by a final round of 
FACS. The solid and dashed red lines indicate respectively the positions of the gates 
used for FACS, and the position of original WT cells as a reference for the extent of 








Probing of the IRE1α tail 
As previously described, the IRE1α tail is likely a flexible and potentially 
unstructured domain that connects the CLD to the TM. Shortening of such a 
flexible tether could well be imagined to restrict the space available that the 
CLD can explore, thus increasing the chance of dimerisation occurring. To test 
this theory, the hydrophobic amino acids (Ala, Leu, Ile, Met, Phe, Pro, Trp, 
Val) of the tail were mutated to alternating glycines or serines to interfere with 
binding sites for potential regulatory factors whilst retaining the overall length 
of the WT sequence (Figure 4.06). Mutation of these residues results in a de-
repressed IRE1, suggesting that the composition of the tail is actually 
important and may provide a binding site for unknown regulatory factors.  
A previous study of IRE1α had identified residues 390-408 as being important 
for repression of IRE1 (Daisuke Oikawa et al., 2009). Interestingly, these 
residues contain a predicted amphipathic α-helix (Figure 1.07 top), which may 
be important for facilitating interactions with regulatory factors in a manner 
dependent on its hydrophobic residues. Mutation of these hydrophobic 
residues (in the endogenous locus) to serines resulted in a moderate de-
repression of IRE1 consistent with the hypothesis (Figure 4.06). However, the 
modest phenotype suggests that other residues of the IRE1 tail are involved in 
Figure 4.03 RT-PCR analysis of the extent of XBP1 splicing in the C13 clone 
compared to the WT parent cell line. The unspliced (XBP1us) and spliced (XBP1s) 
XBP1 species are annotated. In addition, a hybrid XBP1 species can be observed 
comprised of a strand of XBP1us annealed with a strand of XBP1s. 
Table 4.01 The IRE1α protein mutations present in the indicated clones (isolated as 
in figure 4.02) as predicted by genomic and cDNA sequence analysis. 
Figure 4.04 An overview of the ΔLD15 system. Appropriate Cas9-CRISPR guides 
were used to generate a large in-frame 50 kbp deletion between exons 2-11 in the 
WT endogenous IRE1α locus. The IRE1α locus in the resultant ΔLD15 cell line can 
be targeted with a unique Cas9 CRISPR guide and appropriate repair templates of 
the fused IRE1α exons 2-11 to introduce luminal domain variants. The in-frame 
deletion of the ΔLD15 cells results in the expression of IRE1α protein lacking the 




repression or that this mutation of the helix was not sufficient to compromise 
the role it plays.  
The other structural element of the IRE1 tail is the TM proximal amphipathic 
helix, which could also be involved in making interactions with regulatory 
factors. Single point mutations that disrupt the amphipathicity of this structure 
resulted in a strong derepression phenotype (Figure 4.07). Taken together 
these results suggest that multiple sequence elements of the IRE1α tail are 
important for repression of IRE1. 
Mutation of IRE1α residues 312-353 
Molecular details of the BiP:IRE1 interaction catalysed by ERdj4 could give an 
insight into how BiP binding destabilises IRE1 dimers. To obtain these details, 
BiP:IRE1 complexes (formed by ERdj4) were cross-linked and the covalent 
attachment sites identified by mass-spectrometry (data not shown). Analysis 
of the preliminary mass-spectrometry data suggest that BiP may bind residues 
312-353 of IRE1α, which are not resolved in the IRE1α crystal structure 
(Figure 4.08). A Cas9-CRISPR screen (Figure 4.01) was implemented to 
identify mutations in this region that de-repress IRE1α activity (Figure 4.09) 
and though a promising 4µ8c-responsive de-repressed population is seen 
(compare figure 4.09 panel G to figure 4.02 panel E), interpretation of this 










Chapter 4 summary 
This set of mutational analyses of the endogenous IRE1α locus reveal the 
potential importance of amino acid stretches 312-353 and 403-441 in allowing 
repression of IRE1. Though it remains to be experimentally determined, both 
regions are likely required for the formation of a repressive BiP:IRE1 complex. 
The luminal domains of these IRE1 mutants retain the ability to dimerise 
(inferred by the requirement of this event for XBP1us splicing) which builds 
confidence that the mutations do not significantly disrupt the global structure of 
IRE1 but rather interfere with specific sites required for binding of regulatory 
factors. It will be of particular interest to assess the ability of ERdj4 to load BiP 
onto the region 312-353 mutants both in vitro and in vivo once the sequence 













Figure 4.05 Dual channel flow cytometry plots of the XBP1s::Turquoise and CHOP::GFP 
gene reporters of ΔLD15 cells with the endogenous IRE1 locus reconstituted with WT 
IRE1 treated with the indicated ER stressors. To better visualise the repaired population, 
the contour plot mode of displaying raw flow cytometry data was chosen (far right plots) 
instead of the classical pseudo colour dot plot. 
Figure 4.06 Dual channel flow cytometry plots of the XBP1s::Turquoise and CHOP::GFP 
gene reporters of ΔLD15 cells with the endogenous IRE1 locus reconstituted with the 
indicated IRE1 variant: ΔV –deletion of IRE1 residues 403-441, rv GS - hydrophobic 
resides within residues 403-441 mutated to alternating gly/ser, Hel IISS – mutation of the 
α helix (figure 1.07) with F400S, V403S, I404S, L406S mutations. Cells were treated with 
2DG or Tg to reveal the extent of reconstitution and the response still afforded by the 
IRE1 variants. Note that the efficiency of reconstitution is comparable for the IRE1 
variants. 
Figure 4.07 Dual channel flow cytometry plots of the XBP1s::Turquoise and CHOP::GFP 
gene reporters of cells with the endogenous IRE1 locus reconstituted with the indicated 
IRE1 variant: ΔV –deletion of IRE1 residues 403-441, V437R and L441R. Cells were 
treated with 2DG or Tg to reveal the extent of reconstitution and the response still 
afforded by the IRE1 variants. Note that the efficiency of reconstitution is comparable for 




Figure 4.08 hIRE1α LD crystal structure with dashed lines giving an impression of the 
approximate size and location of the unstructured region of residues 312-353. 
Figure 4.09 XBP1s::Turquoise and CHOP::GFP signals from the various cell populations 
elaborated during the on-going Cas9-CRISPR mutation screen targeting residues 312-353 
of IRE1 as outlined in figure 4.01. Sets of WT cells were separately transfected with Cas9 
and guides and pooled (Pop 0 panel A). Pop0 cells with elevated levels of 
XBP1s::Turquoise were collected by FACS (Pop 1 panel C). A second FACS round 
enriched for cells with elevated reporter levels (Pop 2 panel D). Pop 2 was treated with the 
IRE1 inhibitor 4µ8c to identify undesirable cells with mutations that uncouple the reporter 






Chapter 5: In vitro experiments addressing the direct binding 
of unfolded proteins to IRE1α 
Whilst model unfolded proteins have been described to activate IRE1α 
signalling when expressed in vivo, until recently, the absence of known 
specific sequence elements that can drive IRE1α activation has prevented in 
vitro assays assessing facets of this regulatory mechanism. Recently, 
however, a peptide sequence was identified that reportedly binds the IRE1α 
peptide-binding groove (Karagöz et al., 2017). This peptide (MPZN) was 
derived from the model unfolded protein myelin protein zero (MPZ) and has a 
mix of hydrophobic and hydrophilic residues 
(LIRYAWLRRQAALQRRLIRYAWLRRQAA) making it sufficiently soluble for in 
vitro binding assays. Karagöz et al measured the binding of IRE1 and MPZN 
by using a fluorescently MPZN variant in a series of fluorescence polarisation 
anisotropy experiments. They then performed NMR and analytical 
ultracentrifugation experiments to assess the consequences of MPZN binding 
on IRE1’s oligomeric status. The regulation of IRE1 by ERdj4-mediated BiP 
binding does not exclude a regulatory role for direct binding of unfolded 
proteins to IRE1 and it is of interest to study their relative roles in regulation. 
Prior to endeavouring to investigate this, it was first attempted to reproduce 
key findings of Karagöz et al and to further probe the mechanistic details of 
peptide binding further probed. 
MPZN binds IRE1α with an occluded peptide-binding groove 
If the binding site for this peptide is indeed the peptide-binding groove then, no 
binding signal should be obtained when it is incubated with disulfide linked 
IRE1Q105C, which based on the dimer crystal structure of WT IRE1 would be 
predicted to have an occluded peptide-binding groove. To test this hypothesis, 
the fluorescently labeled MPZN peptide (FAM-MPZN) described by Karagöz et 
al was used in anisotropy experiments. As reported by Karagöz et al, a robust 
increase in anisotropy is observed when the peptide is incubated with IRE1α 
(Figure 5.01). However, this increase in anisotropy is still observed when the 
peptide is incubated with disulfide linked IRE1Q105C (Figure 5.02-5.03). This is 
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strong evidence that the peptide does not bind in the peptide-binding groove 
of IRE1α in the manner suggested by the direct binding model.  
The MPZN peptide binds non-specifically to IRE1α 
The effect the peptide has on IRE1 oligomerisation nevertheless still has the 
potential to be physiologically relevant and the actual binding site is therefore 
of interest. To verify that the binding of peptide to IRE1 occurred via a specific 
site increasing concentrations of unlabelled peptide were included in the 
anisotropy assay to compete with the labelled peptide for binding to IRE1. 
However, the presence of this unlabelled peptide does not compete with the 
labeled peptide to prevent the increase in anisotropy (Figure 5.04). Therefore, 
there is no single specific binding site for this peptide on IRE1.  
Chapter 5 summary 
The data shown here suggest that the MPZN peptide does not bind 
specifically to one site on IRE1 nor that binding to IRE1 requires an accessible 
peptide-binding groove. Provided that the anisotropy readings obtained here 
report on the same events as reported by Karagöz et al these data indicate 
that a specific peptide sequence that drives IRE1α oligomerisation by 







































Figure 5.01 Change in anisotropy of 100 nM FAM-MPZN in response to increasing 
concentrations of WT-IRE1. Shown are mean anisotropy values ± SD from three independent 
experiments. Anisotropy is calculated as (Ipara – Iperp)/(Ipara + 2*Iperp) 
Figure 5.02 Coomassie stained non-reducing SDS-PAGE gel of WT-IRE1 and IRE1Q105C ox. 
Figure 5.03 Anisotropy of 100 nM FAM-MPZN in the presence of the indicated concentration 
(µM) of WT-IRE1 or IRE1Q105C ox. Shown are mean anisotropy values ± SD from three 
independent experiments. 
Figure 5.04 Anisotropy of 100 nM FAM-MPZN in the presence of 27 µM WT-IRE1 and the 
indicated concentration (µM) of unlabelled MPZN competitor. Shown are mean anisotropy values 
± SD from three independent experiments. 
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The data presented here describe the in vivo to in vitro journey of identifying 
and validating ERdj4 as an IRE1α repressor which it achieves through its 
ability to interact with IRE1α and stimulate the ATP-hydrolysis of BiP thereby 
guiding BiP to bind IRE1. This thesis also shows how mutational analysis of 
IRE1α can identify regions of potential importance for the mechanisms 
responsible for IRE1 regulation. Finally, experimental data are presented that 
call in to question the current evidence for the direct binding model of IRE1α 
regulation. 
 
What is the stress sensor? 
BiP abundance in the ER 
In eukaryotic cells, BiP is highly abundant (>200 µM), whereas IRE1 is scarce 
(Ghaemmaghami et al., 2003; Kim et al., 2014). Given this stoichiometry, it 
has been argued that BiP repression cannot be reconciled with the high 
sensitivity of the UPR (Pincus et al., 2010). However, this argument does not 
acknowledge the importance of “free” BiP (BiP available to engage with 
substrate) in repressing IRE1. In vitro this is exemplified by the ability of the 
GRP170 NEF to increase both the amount of BiP recruited to IRE1LD and the 
rate of IRE1LD monomerisation as explained by GRP170’s ability to recover 
BiP molecules that have futilely hydrolysed ATP without recruitment onto 
IRE1LD, thereby increasing the concentration of ATP-bound, i.e. “free”, BiP. 
This principle holds true in vivo where analysis of cell lysates suggests that the 
pool of “free” BiP is small: most of the BiP detectable on native gels is either 
substrate bound, engaged in inactive BiP oligomers or inactivated by 
AMPylation (Freiden et al., 1992; Preissler et al., 2015a; Preissler et al., 
2015b). Therefore, despite the abundance of BiP protein, the buffer of “free” 
BiP available to repress IRE1 is likely rather modest, thus explaining the 
sensitivity of the system to stress.  
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Even if the amount of “free” BiP were not so carefully regulated the discovery 
of the role played by ERdj4 in IRE1 regulation provides an alternate solution to 
the high sensitivity to stress exhibited by the UPR branches. 
Depletion of co-chaperone rather than chaperone 
The strict requirement for a J-protein for repressive complex formation 
suggests that competition may also occur at the level of the co-chaperone. 
ERdj4, far less abundant than BiP, likely possess affinity for certain unfolded 
proteins through its C-terminal targeting domain (Shen et al., 2002; Dong et 
al., 2008). Since ERdj4 is similarly dependent on this domain to repress IRE1, 
both in vitro and in vivo, it follows that the canonical chaperone substrate 
interaction underlying IRE1 repression could be out-competed by non-IRE1 
ERdj4 ligands and serve as selective activators of the IRE1 branch of the 
UPR. Currently ERdj4 has been shown to bind to a single known substrate: 
the misfolded substrate protein SP-CΔexon4 via its C-terminal domain (Dong et 
al., 2008). SP-CΔexon4 is indeed seen to be an activator of the UPR, though it 
does not display selectivity for the IRE1 branch (Maguire et al., 2012; Nguyen 
and Uhal 2016). Going forward it would be of interest to identify whether the 
IRE1 branch is particularly sensitive to SP-CΔexon4 when expressed at low 
levels and if other ERdj4 substrates exist. 
Selective regulation of the mammalian UPR branches 
The discovery of ERdj4’s role in IRE1 repression ties in to the prevalent 
understanding that differential activation of the UPR branches elicits different 
consequences for the cell and resolution of the initial stress insult (Chiang et 
al., 2012; Shoulders et al., 2013; Hetz et al., 2015; Adamson et al., 2016). 
This is not so surprising given that, despite some overlap, each branch has 
unique elements to its transcriptional programme e.g. the IRE1/XBP1 branch 
is essential for the strong upregulation of ERdj4 and ERdj6 whilst the ATF6 
branch is primarily responsible for the upregulation of BiP (Lee et al., 2003; 
Shoulders et al., 2013).  
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For example, one could imagine instances where the increased folding 
capacity of the ER by IRE1 and ATF6 activation without decreasing global 
protein synthesis through PERK activation could be beneficial. 
ERdj4 is among other cofactors suggested to play a role in UPR branch 
specific regulation and, in some cases, pathogens have evolved to exploit 
these during infection (X. Shen et al., 2005; Gupta et al., 2010; Kato et al., 
2012; Chen et al., 2014; Taguchi et al., 2015). 
It seems plausible that the different mammalian UPR branches evolved such 
that subtly different UPR programmes could be initiated that were tailored to 
respond to the stress that activated them. Does ERdj4 respond to a particular 
type of stress that other ERdj proteins do not? For example, does ERdj4’s in 
vitro dependence on a disulfide between its cysteine residues connect 
physiological changes in the redox state of the ER to IRE1 activation? Further 
studies that scrutinise ERdj4 during stress conditions are required to address 
this. 
 
Redundancy in IRE1 repression 
ERdj4 is not the sole repressor of IRE1  
The data presented here show that ERdj4 is required for repression of IRE1α 
in the absence of stress and this repression is alleviated during stress.  
There exist further hints in the literature that there is a special relationship 
between ERdj4 and the IRE1 branch as the ERdj4 gene is selectively up-
regulated by IRE1/XBP1 activity (Adamson et al., 2016; Lee et al., 2003) and 
the phenotype of ERdj4 inactivation in mice mimics XBP1 overexpression 
(Fritz and Weaver 2014). 
However, there is clearly redundancy in the regulation of IRE1 given that ER 
stressors can further activate IRE1 in cells lacking ERdj4 (Figure 2.08-
2.09+2.11) and mutations in region V (a region not involved in the mechanism 
of ERdj4 repression) result in de-repression of IRE1 (Figure 4.06-4.07). But 
what are these other mechanisms of IRE1 regulation? The direct binding 
mechanism may be involved in further activation of IRE1 during stress, 
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however, it is currently proposed to involve only the CLD thus eliminating it as 
a candidate for explaining the de-repressing mutations of region V. 
In the absence of other mechanisms of IRE1 activation by protein stress, only 
the chaperone inhibition mechanism remains, raising the possibility of a role 
for other ERdj proteins in regulating IRE1 activity (by contributing to BiP 
repression of IRE1). Unlike ERdj4, which appears to act on the CLD, these 
alternate ERdj proteins may bind to the IRE1 tail and load BiP onto sites 
similar or distinct from those used by ERdj4.  
ERdj2, the translocon and IRE1 
From the ERdj knock out screen, ERdj2 emerges as an additional candidate 
for IRE1 regulation, though it is not clear whether this is due to global 
perturbation of ER proteostasis or de-repression of the IRE1 and PERK 
branches that arises independently of any increase in the burden of unfolded 
proteins (Figure 2.02). It is worth considering that ERdj2 may play a specific 
role in chaperone inhibition, especially given its association with the translocon 
complex, a convenient position as a sensor for the protein folding load of the 
ER. 
The Sec translocon complex is responsible for the co-translational insertion of 
proteins into the ER membrane or lumen. The translocon consists of several 
components, some more essential than others to the function of the whole. 
The relevant components for this discussion are the Sec61 heterotrimer and 
Sec63 (i.e. ERdj2). Sec61, consisting of α, β, and γ subunits, forms the core 
pore complex that facilitates access from the cytosol into the ER (Johanna 
Dudek et al., 2015). Sec63/ERdj2, is a J-domain-containing, multipass-
transmembrane protein whose main role is thought to be to load BiP onto the 
nascent polypeptide emerging from the translocon to aid its import into the 
lumen and folding (Brodsky et al., 1995; Lyman and Schekman 1995; Craven 
et al., 1996; Matlack et al., 1999).  
A link between IRE1 regulation and the translocon is suggested by recent 
papers. Genetic evidence comes from a screen for genes that, when knocked 
out, activate the IRE1 branch, which identified the major translocon 
components, including the Sec61 subunits and ERdj2 (Adamson et al., 2016). 
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More directed work has been carried out by the Malaiyalam Mariappan lab 
who report that an interaction between IRE1 and the translocon is important 
for regulating the activity of IRE1 as reported in Plumb et al., 2015 and 
Sundaram et al., 2017.  
Plumb et al., report on an interaction of IRE1α with ERdj2 and Sec61 subunits. 
The Sec61:IRE1 interaction is dependent on the luminal IRE1 residues 434-
443 and, unlike the BiP:IRE1 interaction, is insensitive to stress. Analysis of 
these mutants and Sec61α-siRNA knock down experiments suggested that 
the Sec61:IRE1 interaction is important for efficient splicing of XBP1us mRNA 
by IRE1 during stress.  
The translated XBP1us contains a pseudo-TM domain that is partially inserted 
into the ER membrane (Yanagitani et al., 2009; Yanagitani et al., 2011). 
Additionally, the XBP1us mRNA contains a translation pause sequence after 
the pseudo-TM domain. Combined these features result in increased 
localisation of the XBP1us mRNA to the ER membrane in close proximity to 
the translocon. 
Building on this and further experiments, Plumb et al concluded that the 
translocon serves as a hub to confine XBP1us mRNA and IRE1 together such 
that during stress splicing can proceed more swiftly and efficiently.  
The finding that the Δ434-443 IRE1 splices less XBP1us than WT but has 
higher basal phosphorylation levels led Sundaram et al to further explore the 
Sec61:IRE1 interaction using IRE1 mutants with either disrupted or enhanced 
interaction with Sec61. They found that the strength of the Sec61:IRE1 
interaction correlates positively with the ability to splice XBP1us and correlates 
inversely with the propensity for IRE1 to activate (phosphorylation and cluster 
formation). The Mariappan lab interpret their data to mean that the 
Sec61:IRE1 interaction favours repression of IRE1 activity (at the level of 
auto-phosphorylation) whilst enhancing the efficiency of XBP1 splicing by 
activated IRE1.  
The sites of IRE1α that facilitate the interaction with the translocon are located 
in the tail region which, as described in the introduction, has been implicated 
in Kar2/BiP binding and IRE1 activity.  
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It is interesting to note that Myc-PERK harbouring a LD deletion adjacent to 
the TM has fewer BiP molecules associated with it than WT and has elevated 
levels of auto-phosphorylation (Ma et al., 2002). 
Taking into account the described published literature and the data presented 
in this thesis it is tempting to propose that translocon-associated ERdj2 may 
couple IRE1/PERK signalling directly to the flux of proteins imported into the 
ER. When the flux is low, ERdj2 recruits BiP to IRE1/PERKLD. During periods 
of high secretory activity, ERdj2 is engaged facilitating translocation, thereby 
allowing IRE1/PERK to dimerise and activate. Through this coupling, the UPR 
may activate even before unfolded proteins begin to accumulate in the ER. 
Such a pre-emptive UPR activation would be very advantageous to the cell. 
In this thesis, deletions in the IRE1α tail region are seen to increase IRE1’s 
basal activity as measured by XBP1 splicing (Figure 4.06) which contrasts 
with Mariappan and Iwawaki lab observations (Daisuke Oikawa et al., 2009; 
Plumb et al., 2015; Sundaram et al., 2017). It is difficult to reconcile these 
differences but the simplest explanation is that cellular expression levels are 
hard to maintain reproducibly at endogenous levels in the experimental 
systems used in these studies (transient transfections and leaky expression 
from a doxycycline regulated promoter). As previously mentioned, IRE1 
expression levels can dramatically influence its activity and exogenous 
expression of IRE1 therefore has the potential to yield misleading data 
(Daisuke Oikawa et al., 2009) and even Sundaram et al themselves show the 
importance of IRE1 expression levels.  
This discussion of expression levels potentially yielding misleading 
experimental outcomes raises an important issue. The advent of Cas9-
CRISPR technology has revolutionised cell biology and should set new 
standards for experiments assessing gene function in vivo. Using Cas9-
CRISPR, it is now easier to consistently ensure homogenous protein 
expression at physiologically relevant endogenous levels within a perturbed 
cell population, as opposed to expression experiments relying on transient 
transfections (Figure 2.06) or random genome integration events. Knock down 
and over-expression systems need no longer be the only techniques used to 
manipulate gene expression. 
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Key experiments in this thesis therefore make use of the Cas9-CRISPR 
technology to introduce mutations into the endogenous gene locus of IRE1, 
such that its expression levels remain correctly regulated and physiologically 
relevant.  
Currently, ERdj2 is the most plausible candidate for additional ERdj-mediated 
regulation of IRE1 (and PERK) but ERdj2 may behave very differently to 
ERdj4 in the manner in which it represses signalling. In contrast to the direct 
contacts made by ERdj4, ERdj2 is not thought to interact directly with its 
substrate (nascent polypeptides), yet it is still able to load BiP onto them. 
Spatial positioning of ERdj2 in proximity to substrate is instead important and 
this could well be the case if ERdj2 is required for IRE1/PERK regulation 
(sequence elements in the tail of IRE1 may be required to ensure the correct 
positioning of IRE1 relative to ERdj2). The lack of a direct interaction between 
ERdj2 and substrates, coupled with it being a multipass membrane protein 
may make in vitro studies of its role in IRE1/PERK regulation very difficult.  
Roles of the other ERdj proteins 
The diverse nature of the ERdj proteins means they are involved in a range of 
different ER proteostasis events. For example, ERdj1 (like ERdj2) is thought to 
be important for co-translational import into the ER, ERdj3 and ERdj6 
potentially play a role in chaperoning folding and ERdj5 is involved in altering 
disulfides and ERAD. Despite this, the ER environment is not obviously 
perturbed when these ERdj proteins (other than ERdj2) are individually 
knocked out suggesting a surprisingly large degree of redundancy in the roles 
they play, at least in CHO cells used in our study (Figure 2.02). This 
redundancy may have masked any role played by the other ERdjs in IRE1 or 
PERK branch regulation and raises interesting questions about ERdj4 and 
why the burden of IRE1 regulation seems predominantly borne by it. 
Combinatorial knock outs would be required to assess the extent of 
redundancy between the ERdj co-chaperones and how they cooperate to 
maintain ER proteostasis. 
The yeast genome encodes four ERdj proteins, Scj1, Sec63, Jem1 and ERj5 
(some of which have mammalian homologues) and one or more may be 
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required to facilitate formation of a Kar2:IRE1 complex. Some evidence for a 
de-repressed UPR can be seen in yeast lacking either Scj1 or Jem1 
consistent with a role of these ERdjs in repressing IRE1 (Silberstein et al., 
1998; Famá et al., 2007). Experiments similar to those outlined in this thesis 
may be a suitable starting point to understanding whether yeast ERdjs play a 
role in IRE1 regulation and provide further support to the chaperone inhibition 
model. 
 
Other reported aspects of IRE1 regulation 
The direct binding model vs chaperone inhibition 
There is a large body of literature, mainly focused on yIRE1, championing the 
direct binding model as being crucial to IRE1 regulation. Several UPR 
activating model-unfolded protein substrates have been reported to bind IRE1 
and drive oligomerisation. The group of Peter Walter has thoroughly probed 
such proteins for the peptide sequences facilitating their interaction with IRE1. 
For yIRE1, the sequence of model unfolded protein mutant CPY was screened 
for sequences that bind yIRE1 and the highest affinity peptide (F17) was a 
15mer which bound with a K1/2 of 172 µM (Gardner and Walter 2011)6. More 
recently, proinsulin, MPZ and 8PI were similarly interrogated for sequences 
that bind IRE1α and the highest affinity peptide was the 12mer MPZN, which 
bound with a K1/2 of 16 µM (Karagöz et al., 2017).  
The data presented in this thesis suggest that the MPZN peptide is unlikely to 
bind solely across the MHC-like peptide-binding groove of IRE1α, as its 
binding is not disrupted by a disulfide bond that occludes the groove (Figure 
                                            
6 A peptide with higher binding affinity than F17 was also identified by 
Gardener et al., 2011. This peptide, ΔEspP, is a signal peptide and has a K1/2 
of 0.75 µM. The mutation of the MFY residues of yIRE1 increases the K1/2 to 
42 µM, though this is still a higher affinity than F17 displays for yIRE1. Signal 
peptides are not normally expected to be present in the ER lumen and it is still 




5.03). This finding, together with the observation that activation of IRE1αQ105C, 
in cells favours formation of a disulfide (Figure 2.23), argues against an 
important role for peptide binding in IRE1 activation. 
Karagöz et al also discovered that the 2xMPZN peptide, consisting of two 
joined copies of the MPZN peptide, has a higher affinity for IRE1α (K1/2 of 0.6 
µM). At concentrations equal to or below that of IRE1α, presence of the 
peptide stabilises soluble oligomers. Presence of 2xMPZN in molar excess of 
IRE1α, however, results in precipitation of IRE1α (data not shown and 
correspondence with Elif Karagöz). It is currently unclear whether precipitation 
occurs due to formation of stress-relevant oligomers or non-specific 
aggregates and the effect may still be manifest at lower concentrations of 
2xMPZN relative to IRE1. 
A competition experiment (as carried out in figure 5.04) is also lacking from 
the study identifying peptides that drive oligomerisation of yIRE1 (Gardner and 
Walter 2011). Given the importance of the in vitro fluorescent polarisation 
experiments in the Gardner and Karagöz papers as evidence supporting a role 
for direct binding of peptides to IRE1 for regulation, it is important to determine 
to what extent they are reliable indicators of a single, specific binding site as 
proposed by the direct binding model. If it holds true that MPZN (and the 
yIRE1 equivalent) indeed bind IRE1 non-specifically at multiple sites and drive 
it into non-physiologically relevant aggregates then little convincing published 
data remains supporting the direct binding model.  
To regain support for the direct binding model a peptide sequence motif would 
need to be identified that: binds specifically to and drives dimerisation of IRE1 
both in vivo and in vitro, is present and exposed in model unfolded proteins, 
and is found in high abundance in the ER proteome to ensure that the UPR is 
sensitive to the accumulation of any type of unfolded protein. Crosslinking or 
crystallography experiments could be useful to better characterise the binding 
sites for such peptides on IRE1.  
ERdj4-directed BiP repression is played out at the level of the minimal 
structured core IRE1LD, sufficient for UPR regulation (Daisuke Oikawa et al., 
2009). In pure solution, core IRE1LD protomers have a high affinity for each 
other and dimerise without addition of peptides (Zhou et al., 2006). 
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Furthermore, as noted above, the formation a stress-dependent IRE1LD Q105C 
disulfide is difficult to reconcile with an extended unfolded protein engaging 
the proposed peptide-binding groove of IRE1LD as the initiator of IRE1LD 
dimerisation.  
Given the current experimental data, it seems likely that chaperone inhibition 
is the main regulator of IRE1α and if unfolded protein binding contributes, it 
seems it does so not by altering the monomer-dimer equilibrium, which lies at 
the heart of the UPR, but rather by influencing the formation of higher order 
IRE1α oligomers, whose function remains to be determined. Whilst chaperone 
inhibition and direct binding mechanisms are not mutually exclusive, it does 
not seem necessary at this stage to produce a contrived model of IRE1α 
regulation encompassing both mechanisms given that chaperone inhibition 
seems both necessary and sufficient to describe the behaviour of IRE1α. 
yIRE1 compared to the mammalian IRE1 isoforms 
Yeast and mammals last shared a common ancestor ~1.2 billion years ago. It 
would not be surprising to find that different mechanisms of IRE1 regulation 
have evolved since that divergence. The most convincing data supporting 
chaperone inhibition and direct binding/IRE1 oligomerisation come from 
mammalian and yeast IRE1 studies respectively. In vitro experiments 
exploring the role of chaperone inhibition of yIRE1 are still lacking but the 
current consensus is that binding of Kar2 to region V attenuates yIRE1 activity 
during prolonged stress (Pincus et al., 2010; Ishiwata-Kimata et al., 2013; 
Mathuranyanon et al., 2015) and potentially desensitises yIRE1 to stress 
(Pincus et al., 2010). Attenuation of IRE1 activity may influence cell survival 
during the UPR, as seen by the increased mortality of cells expressing yIRE1 
mutants lacking region V exposed to ethanol or heat-stress (Kimata et al., 
2004).  
Generally yeast and mammalian IRE1 have not been directly compared in a 
single study, however, the few that have done this see clear differences in the 
properties of the two proteins that may be linked to their mechanism of 
regulation. Such studies have led to the suggestion that yIRE1 is regulated by 
both chaperone inhibition and direct binding and that these regulatory 
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mechanisms have been partitioned between the mammalian IRE1 isoforms. 
This compromise suggests that IRE1α is regulated by chaperone inhibition, 
and not direct binding, whilst the converse is true for IRE1β (Daisuke Oikawa 
et al., 2012). This is supported by the observation that IRE1β performs more 
efficiently in anti-aggregation assays (in vitro) and interacts more with model 
unfolded proteins in pull down assays compared to IRE1α (Daisuke Oikawa et 
al., 2012). It is unclear whether a stress-sensitive BiP:IRE1β complex forms 
(Bertolotti et al., 2000; Daisuke Oikawa et al., 2012) but there seem to be clear 
differences between the cytosolic events catalysed by IRE1α vs IRE1β. Over 
expression of IRE1β is seen to increase cell apoptosis relative to IRE1α 
(Iwawaki et al., 2001). In addition, the substrate specificity of the IRE1β and 
IRE1α RNase domains differ allowing IRE1β to cleave for example 28S rRNA 
to decrease the synthesis of secreted proteins (Iwawaki et al., 2001; Imagawa 
et al., 2008; Nakamura et al., 2011). 
As further work is done to understand the mechanisms of yIRE1 and IRE1α 
regulation, the reported differences described here and in the introduction may 
persist and demonstrate how regulation of conserved proteins can diverge.  
 
The molecular detail of chaperone inhibition 
BiP and ERdj4 binding sites on IRE1 
It will be exciting to pursue a high-resolution map of the interaction sites 
between IRE1 with ERdj4 and BiP, and the following predictions can already 
be made regarding these interaction sites. Binding sites sufficient for ERdj4 
binding and for repressive BiP binding exist in the CLD (Figure 3.22). Both 
sites are accessible in Q105C disulfide linked IRE1 dimers and therefore the 
binding sites are unlikely to be at the dimer interface suggesting the repressive 
mechanism is allosteric rather than a steric blocking of the interface (Figure 
3.16-3.18). The binding site of BiP is likely on an exposed loop protruding from 
the core globular IRE1CLD due to the structural constraints of BiP substrate 
binding, which favours interactions with extended polypeptides (Zhu et al., 
1996; Rüdiger et al., 1997). 
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These predictions marry well with preliminary experimental data from the 
mass-spectrometry and mutagenesis approaches indicating a role for IRE1α 
residues 312-353 in binding BiP. Given their absence from the crystal 
structure, these residues are likely unstructured or flexible making them a 
more accessible substrate for BiP. 
Though algorithms exist for predicting the sites of BiP binding in proteins 
(Blond-Elguindi et al., 1993; Schneider et al., 2016), these were created using 
data of unregulated binding of BiP to peptides and may therefore not be 
informative for identifying the sites of ERdj-directed BiP substrate binding. 
In vitro multiple BiP molecules associate with a single IRE1 molecule, possibly 
through multiple binding sites on IRE1 and/or BiP oligomers binding to IRE1 
(Figure 3.06). Given the difficulty of measuring the stoichiometry of the 
endogenous BiP:IRE1 complex, it is difficult to assess whether the in vitro 
observations on stoichiometry mirror the in vivo system. As discussed, the in 
vivo pool of “free” BiP is likely small and significant amounts of BiP oligomers 
are only known to actively assemble in response to the stress of ER calcium 
depletion (Preissler et al., 2015b). Therefore, if multiple BiP molecules do 
associate with IRE1 in vivo, it seems unlikely that the repressive endogenous 
BiP:IRE1 complex comprises of oligomeric BiP. It is more likely that multiple 
binding sites on IRE1 for BiP exist and could provide a mechanism for the 
gradual activation of IRE1 in response to mounting stress. 
Whilst there is hope that the BiP:IRE1 interaction can be properly 
characterised, it will likely not be as simple to establish the binding site for 
ERdj4 on IRE1 given the difficulty of working with this protein. However, some 
details of the interaction can still be discussed in light of the data presented 
here. 
The nature of the ERdj4:IRE1 interaction 
BLI data reproducibly reports on a very high affinity interaction between IRE1 
and ERdj4 and is independent of which component is used as the biotinylated 
ligand (Figure 3.11-3.12). This interaction is disrupted by ERdj4-mediated 
loading of BiP onto IRE1 and requires hydrolysis of ATP. Hints of this high-
affinity interaction have also been observed indirectly via the FRET system. 
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ERdj4QPD is a strong inhibitor of ERdj4/BiP/ATP disruption of IRE1 dimers 
consistent with the idea that ERdj4QPD binds to IRE1 and cannot activate BiP 
to displace itself from IRE1, thereby blocking ERdj4WT from binding and 
loading BiP to inhibit dimerisation (data not shown). This displacement of ERdj 
by BiP from its substrate has some precedent with a QPD ERdj3 and 
immunoglobulin light chain intermediates (Y. Shen and Hendershot 2005).  
Some puzzling aspects of the ERdj4:IRE1 interaction remain to be 
understood. In contradiction to the displacement of ERdj4 by BiP seen in vitro, 
in vivo co-immunoprecipitation reveals a reproducible interaction between 
IRE1LD-GST and ERdj4WT but not ERdj4QPD (data not shown). This finding 
may represent an uninformative and confusing experimental artefact (as both 
the IRE1 and the ERdj4 partners of this interaction are over-expressed), 
however it may also be explained by accumulation of ERdj4 specific substrate 
in ΔERdj4 cells. When ERdj4WT is expressed these substrates bind ERdj4 and 
are cleared, leaving ERdj4 free again. However, in the absence of a functional 
J-domain, the pool of ERdj4QPD instead becomes sequestered by these 
substrates with fewer molecules available to associate with the IRE1 luminal 
domain. The idea that ERdj4 may be involved in aspects of proteostasis other 
than repressing IRE1 via BiP loading is supported by the finding that over-
expression of ERdj4QPD in ΔERdj4 cells retains some ability to repress the de-
regulated IRE1, which is not seen in vitro (Figure 2.05). 
An ERdj4:IRE1 interaction is not always apparent in vitro. The pull-down 
system used in this thesis does not reproducibly reveal an ERdj4:IRE1 
interaction above the background binding of purified recombinant ERdj4 to the 
streptavidin beads used. This suggests that further optimisation of the binding 
conditions is required before drawing conclusions. In addition, a stable 
ERdj4:IRE1 complex in the size exclusion chromatography data set was not 
detected (Figure 3.06), which is difficult to reconcile with the very low off rates 





The repressive BiP:IRE1 complex forms through a canonical 
chaperone-substrate interaction 
The work in this thesis provides evidence that the repressive BiP:IRE1 
complex is formed through a canonical chaperone substrate interaction as 
directed by a co-chaperone rather than a non-canonical alternative. This is 
difficult to reconcile with the data presented by the group of Maruf Ali who 
have published a comprehensive set of in vitro experiments showing the BiP-
IRE1 interaction to be NBD-mediated, SBD independent and nucleotide 
insensitive (Carrara et al., 2015b; Kopp et al., 2018). 
Though few BiP-IRE1 in vitro experiments have been published, some 
information about the nature of the BiP:IRE1 interaction can be gleaned from 
in vivo studies, which support it being a canonical chaperone substrate 
interaction (Bertolotti et al., 2000; Kimata et al., 2003; Liu et al., 2003). The 
findings of the Ali group are partly supported by the in vivo study of Todd-
Corlett et al, who show that presence of glycans around the Kar2 NBD but not 
the SBD are able to prevent the BiP:IRE1 interaction. This data and further 
mutational analysis suggests that the Kar2 NBD is responsible for mediating 
the interaction with yIRE1 (Todd-Corlett et al., 2007). It is important to note 
that to date, other than those of the Ali group, studies supporting that the 
BiP:IRE1 interaction is non-canonical do not suggest that it is insensitive to 
nucleotide (Todd-Corlett et al., 2007; Sou et al., 2012). 
Some of the findings of Carrara et al may be reconciled by taking into account 
the different experimental conditions used. For the striking pull down data BiP 
variants were incubated with 500 µM (150 µM for Kopp et al., 2018) of binding 
partner (IRE1 etc.), which may facilitate non-physiological interactions 
between the components. In addition, the Ali group may not see association of 
SBD with IRE1 because of the short incubation time (1 hr) used in all binding 
experiments which, due to the low kon of the isolated (un-regulatable) BiP 
SBD, is likely not enough to be able to claim that no binding occurs.  
It should again be emphasised that in vivo the capacity of BiP to function is 
thought to be completely dependent on regulation by ERdj and NEF co-
chaperones (Otero et al., 2010). Whilst the Ali group convincingly show that 
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under certain experimental conditions BiP-NBD but not BiP-SBD can bind 
IRE1, the data presented in this thesis and the current knowledge of the 
Hsp70 field all suggest that NBD binding and the observed nucleotide 
insensitivity is not physiologically relevant to IRE1 regulation in vivo. 
 
The validity of IRE1Q105C as a tool 
Some important conclusions of this thesis rest on the validity of disulfide linked 
IRE1Q105C representing stress relevant IRE1 dimers, namely the ability of 
ERdj4 to favour IRE1 monomers in vivo (Figure 2.27) and the ability of ERdj4 
to load BiP onto IRE1 dimers in vitro (Figure 3.16-3.18). 
Though it has not been proven that the endogenous IRE1Q105C forms Q105C-
Q105C homodimers rather than heterodimers with an unknown entity, the 
existence of the former when overexpressed (Figure 2.26) and in vitro (Figure 
5.02) makes it reasonable to assume that it does. 
As described the endogenous IRE1Q105C also contains the C109S mutation, 
which could be corrupting to the protein however previous studies have 
determined that C109 is not important to IRE1α’s function. In total, the WT 
IRE1αLD has 3 endogenous cysteines, C109, C148 and C332, and disulfide 
linked IRE1α species have been observed which are dependent on C148 and 
C332. However, formation of these disulfides is not important for IRE1α folding 
or dimerisation (Liu et al., 2002; Liu et al., 2003; Daisuke Oikawa et al., 
2009)7. 
                                            
7 As mentioned IRE1α LD disulfides are not thought to be a critical post-
translational modification for its function. IRE1α LD also has a single predicted 
N-linked glycosylation site which has been seen to be glycosylated, however 
the folding and dimerisation of IRE1α is not dependent on the integrity of this 
site (Chuan Yin Liu et al., 2002). The insensitivity of IRE1α functionality and 
structure to its glycosylation and disulfide states makes it a robust protein to 




Disulfide bond formation between IRE1 molecules or other proteins may have 
subtle effects on IRE1α e.g. slower attenuation of IRE1α activity during/post 
stress due to an inability to interact with PDIA6 (via C148) which has been 
reported to dissociate from IRE1α in response stress before reassociating 
during stress resolution and IRE1α attenuation (Eletto et al., 2014). 
All this being said, it seems likely that IRE1Q105C is indeed a suitable tool for 















                                                                                                                             
glycosylation machinery or the redox environment of the ER and is likely an 




A proposed model for IRE1 regulation 
A final model for the mechanism of IRE1α regulation is shown incorporating 
the data from this thesis and observations from the literature (Figure 6.05). In 
the absence of stress, when the folding load is low, there is sufficient available 
J-activity (from ERdj2 and ERdj4) and “free” BiP to maintain the IRE1 
population in inactive monomers. The monomer population is stabilised 
through active disruption of IRE1 dimers and through the inability of BiP-IRE1 
monomers to dimerise. Both of these are achieved through a dynamic, non-
equilibrium, ATP-consuming process of J-protein-driven cycles of BiP 
rebinding to IRE1LD and release following nucleotide exchange. During stress, 
available J-activity and “free” BiP is depleted by the increased folding load and 
becomes insufficient to maintain the inactive IRE1 population. 
The J-protein driven ATP hydrolysis of BiP provides the energy for the 
described mechanism of IRE1 inactivation. The dynamic nature of this 
mechanism, provided by NEF, allows the system to continually sample the ER 
environment, which is required for sensitivity to changes. At the heart of this 
mechanism is that the ERdj-mediated BiP:IRE1 complex is a canonical co-
chaperone formed chaperone-substrate complex as it allows unfolded proteins 




6.01 The proposed model of IRE1α regulation (see main body text for full 
description). The question mark in the above panel indicates uncertainty about the 
role of BiP in binding the IRE1α tail in regulating IRE1 activity. Faded images 





Since the discovery of the eukaryotic unfolded protein response, the 
mechanism by which ER proteostasis is monitored has been sought. The 
discovery of an ER-localised J-protein that selectively represses IRE1 activity 
has, for the first time, allowed reconstitution of a UPR that is based on sensor 
repression by free BiP and de-repression by accumulating unfolded proteins. 
By incorporating this missing component the experiments presented in this 
thesis have closed an important gap between the finding that activity of the 
UPR transducers in cells correlates inversely with the amount of associated 
BiP and a plausible explanation for how this might come about.  
Though direct binding originally emerged as an elegant hypothesis for IRE1 
regulation this thesis reveals that the most compelling published data 
supporting it are potentially misleading. Consequently, direct binding remains 
a mere model that awaits further experimentation to restore it to being an 
accepted mechanism for IRE1α regulation. 
By exploiting the diversity of functionalities associated with J-proteins, BiP-
mediated repression of ER stress transducers throughout eukaryotes may 
have developed as a conserved, sensitive and potentially versatile mechanism 








































Information on key oligonucleotides and plasmids used in this thesis is 
provided in appendix tables 1 and 2.  
CHO cell line 
A parental stock of Chinese Hamster Ovary CHO-K1 cells (ATCC, CCL-61) 
was used. Its identity has been validated by the presence of auxotrophic 
markers and by deep sequencing of the genome. 
CHOP::GFP and XBP1::Turquoise reporters were introduced sequentially 
under G418 and puromycin selection to generate the previously-described 
derivative CHO-K1 S21 clone (Sekine et al., 2016). The puromycin resistance 
marker was subsequently lost, rendering CHO-K1 S21 cells sensitive to 
puromycin. 
Adherent Chinese hamster ovary (CHO) cell-lines were grown in Ham’s 
nutrient mixture F12 (Sigma). All cell media was supplemented with 10% 
Hyclone FetalClone-2 serum (FetalClone II, Hyclone-GE Healthcare Life 
Sciences, South Logan, UT Lot# ABB214492), 2 mM glutamine (Sigma), 100 
U/ml penicillin and 100 µg/ml streptomycin (Sigma). Cells were grown at 37°C 
in 5% atmospheric CO2. 
Bacterial culture 
Proteins were expressed in BL21 C3013 E. coli cells or Origami B(DE3) cells 
(NEB). Bacterial cultures were grown at 37˚C in LB medium containing 100 
µg/ml ampicillin to an OD600nm of 0.6-0.8. Expression was induced with 0.5 mM 
isopropylthio β-D-1-galactopyranoside (IPTG) and the cells were incubated for 
16 hours at 18˚C.  
DNA amplification PCR/RT-PCR 
RNA was extracted as per a standard phenol:chloroform extraction. Briefly 
RNA STAT 60 was used to lyse cells and gDNA sheared with needle. 0.3 M 
NaOAc was added and two sequential phenol:chloroform extractions 
performed. The RNA was then precipitated in isopropanol and washed in 70% 
EtOH before resuspending in RNase-free water. The reverse transcription 
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reaction was primed with oligo dT and the subsequent PCR reaction primed 
with primes 5 and 1470. 
Cell culture 
Thapsigargin (Calbiochem) treatment was at 0.5 µM. Tunicamycin (Melford) 
treatment was at 2.5 µg/ml for 16 hours unless otherwise stated. 2-
Deoxyglucose (Sigma) treatment was at 4 mM for 16 hours. Dithiothreitol 
(DTT) (Sigma) treatment was at 2 mM for 15 minutes. 4µ8c (Cross et al., 
2012) treatment was at 10 µM for 12 days.  
Transfection 
Cells were transfected using Lipofectamine LTX (Life Technologies) with the 
reduced serum medium Opti-MEM (Life Technologies) according to 
manufacturer’s instructions. 
Gene manipulation and allele analysis 
Cas9 guide design was aided in part by the online resource “CRISPy” (Ronda 
et al., 2014) several guides were designed manually following standard 
guidelines (Ran et al., 2013). Cells were transfected with the Cas9 and guide 
constructs and grown for a week before analysis by flow cytometry and 
sorting. 
For genotyping, genomic DNA was extracted from cells by incubation in 
proteinase K solution (100 mM Tris pH 8.5, 5 mM EDTA, 200 mM NaCl, 
0.25% SDS, 0.2 mg/ml Proteinase K) overnight at 50°C. Proteinase K was 
then heat inactivated at 98°C for 20 minutes before the supernatant was 
collected and used as a template in PCR reactions before sequencing. To aid 
in interpreting sequencing data of genes modified by Cas9 the changes in size 
of the target gene alleles were determined by cappilary electrophoresis on a 
3730xl DNA analyser (Applied Biosystems). Samples to be analysed by the 
DNA analyser were generated through PCR reactions where one of the 
oligonucleotides had a 5’ 6-carboxyfluorescein (FAM) flurophore modification. 




Creating the endogenous IRE1Q105C 
The endogenous IRE1 locus was challenged with Cas9 guide UK1558 to 
generate a loss of function indel and fluorescence-activated cell sorting 
(FACS) was used to select for XBP1s::Turquoise dull cells after 2-
deoxyglucose (2DG) treatment. The resultant clones were genotyped with 
oligonucleotides 1100/1125 and 1101. After sequencing, a clone (NC6) that 
was apparently homozygous for a single frameshift nucleotide deletion was 
selected. To introduce the Q105C and C109S mutations, the new IRE1 locus 
was challenged with Cas9 guide UK1559 and a PCR-knitting generated repair 
template (oligonucleotides used: 1097, 1098, 1116, 1117 to PCR from CHO 
genomic DNA, see appendix table 4 for repair template sequence). Cells that 
successfully repaired the IRE1 locus were selected using FACS to collect cells 
that were XBP1s::Turquoise bright after 2DG treatment. Resultant clones were 
genotyped with oligonucleotides 1100/1125 and 1101. Two clones (CV1 and 
CV8) were idenitfied by sequencing as homozygous for the repair sequence 
and were used for subsequent experiments. 
Flow cytometry and FACS  
Flow cytometry was carried out on a BD LSRFortessa. Adherent CHO cells 
were washed once in PBS and then incubated for 5 minutes in PBS + 4 mM 
EDTA before harvesting and fixing in PBS + 1.1% paraformaldehyde. Cell 
sorting was carried out on a Beckman Coulter MoFlo Cell sorter. Adherent 
CHO cells were washed once in PBS and then incubated 5 minutes in PBS + 
4 mM EDTA + 0.5% BSA before sorting into fresh media. CHOP::GFP 
fluorescence was measured by excitation at 488 nm and monitoring emission 
at 530/30 nm. XBP1s::Turquoise fluorescence was measured by excitation 
405 nm and monitoring emission 450/50 nm. 
Mammalian cell lysis 
Adherent cells were grown in 10-cm dishes and treated as described above. 
The dishes were then transferred to ice and cells were washed in PBS and 
harvested in PBS + 1 mM EDTA with a cell scraper. The collected cells were 
spun at 370 g for 5 minutes at 4°C. Cells were lysed in 1% Triton X-100, 150 
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mM NaCl, 20 mM HEPES-KOH pH 7.5, 10% glycerol, 1 mM EDTA, 1 mM 
phenylmethylsulphonyl fluoride (PMSF), 4 µg/ml Aprotinin and 2 g/ml 
Pepstatin A and 2 µM Leupeptin. For BiP coimmunoprecipitation experiments 
the lysis buffer lacked EDTA and was further supplemented with 10 mM 
MgCl2, 6 mg/ml glucose and 2 mg/ml Hexokinase (Sigma) to deplete ATP and 
stabilise BiP substrate interactions. For analysis of IRE1 phosphorylation by 
Phostag gel electrophoresis (Yang et al., 2010), the lysis buffer was further 
supplemented with 10 mM tetrasodium pyrophosphate, 100 mM sodium 
fluoride and 17.5 mM β-glycerophosphate. For analysis of IRE1Q105C disulfide 
linked species the lysis buffer was further supplemented with 20 mM N-
Ethylmaleimide (NEM). After 5 minutes of lysis on ice cells were spun at 
21,130 g for 10 minutes at 4°C. The supernatant was transferred to a fresh 
tube and, when necessary, protein concentration measured with BioRad 
protein assay (Bio-Rad). 
To reduce the non-specific binding of BiP to protein-A sepharose beads the 
experiments shown in figure 2.10+2.18 included an additional digitonin 
permeabilisation step (Le Gall et al., 2003) to remove non-membrane 
associated BiP from cells prior to lysis. After harvesting cells were washed in 
HNC buffer (50 mM HEPES-KOH pH 7.5, 150 mM NaCl, 2 mM CaCl2) and 
then incubated in HNC with 0.1% (w/v) digitonin (Calbiochem) for 10 minutes. 
Cells were then washed in HNE buffer (50 mM HEPES-KOH pH 7.5, 150 mM 
NaCl, 1 mM EGTA) before proceeding to the lysis step as described above. 
Antibodies 
Anti-mouse IRE1α serum (NY200) and anti-mouse PERK serum (NY97 & 
NY201) was used for immunoprecipitation and immunoblot detection of 
endogenous IRE1α, PERK and PERK-P respectively (Bertolotti et al., 2000). 
Anti-hamster BiP serum was used for immunoblot detection of endogenous 
BiP (Avezov et al., 2013). Anti-GST serum was used for immunoblot detection 
of GST fusion proteins (Ron and Habener 1992). Anti-FLAG-M2 monoclonal 





Immunoprecipitation and GSH pull-down assays 
Protein A sepharose 4B beads (Zymed Invitrogen), and appropriate antisera 
(against IRE1 and PERK), or Glutathione (GSH) Sepharose 4B beads (GE 
Healthcare) were equilibrated in lysis buffer. For BiP immunoprecipitation anti-
BiP chicken IgY antibodies were covalently bound to UltraLink Hydrazine 
Resin (Pierce cat. # 53,149) according to the manufacturer’s instructions.  
20 µl beads/resin per sample was added to lysates and left rotating for 1 hour 
at 4°C. The beads/resin was then washed in lysis buffer and residual liquid 
was removed using a syringe. The protein from the beads/resin was eluted in 
SDS sample buffer containing 20 mM DTT or 20 mM NEM (for non reducing 
gels). 
SDS-PAGE/Phos-tag SDS-PAGE and immunoblotting 
Samples were separated on standard polyacrylamide Tris-HCl gels and 
transferred to Immobilon-P PVDF membrane (Pore size 0.45 µm, Sigma). The 
membrane was then blocked in 5% (w/v) dried skimmed milk in PBS. For the 
non-reducing gels of endogenous IRE1α the membrane was treated with 
GDHCl buffer (6 M Guanidine-HCl, 250 mM NaCl, 50 mM Tris pH 7.5, 10% 
glycerol) with added 0.2% SDS and 100 mM DTT for 30 minutes then washed 
in GDHCl buffer, and finally treated with GDHCl buffer with added 40 mM 
NEM for 30 minutes. The membranes were then washed three times in TBS 
(50 mM Tris pH 7.5, 150 mM NaCl) and blocked in 5% (w/v) dried skimmed 
milk in PBS before continuing with the standard procedure. After blocking the 
membranes were washed in TBS with 0.1% Tween-20 and stained with 
various primary antibodies/antisera followed by staining with IRDye 
fluorescently labelled secondary antibodies or horse radish peroxidase (HRP) 
labelled secondary antibodies (G21234, ThermoFisher). Super Signal West 
Pico Chemiluminescent substrate (Thermo Scientific) was used as an HRP 
substrate. Imaging was carried out with either a LICOR CLx Odyssey infrared 
imager or by film. For Phos-tag gels, 50 µM Phos-tag acrylamide (NARD) and 
100 µM MnCl2 were included in the gel recipe as described (Kinoshita et al., 
2009). Transfer was carried out according to the standard protocol except that 
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prior to transferring, the Phos-tag gel was washed in transfer buffer 
supplemented with 1 mM EDTA. 
Coomassie-staining was carried out with Instant Blue (Expedeon) and imaged 
on the above-mentioned LICOR. IRE1LD-TAM in SDS-PAGE gels was imaged 




IRE1LD (UK2007), IRE1LD-cys (UK1915) and IRE1CLD-cys (UK1998) used to 
make IRE1LD-biotin (UK1915 and UK2007), IRE1LD-OG (UK1915) and 
IRE1CLD-biotin (UK1998), were encoded on pGEX vectors (GE Healthcare) as 
GST fusion proteins and expressed in BL21 C3013 E. coli cells (NEB). 
Bacterial cultures were grown at 37˚C in LB medium containing 100 µg/ml 
ampicillin to an OD600nm of 0.6-0.8. Expression was induced with 0.5 mM IPTG 
and the cells were incubated for 16 hours at 18˚C. The cells were sedimented 
by centrifugation and the pellets were resuspended in TNGMT buffer (50 mM 
Tris pH 7.4, 500 mM NaCl, 10% glycerol, 1 mM MgCl2, 1 mM TCEP). The cell 
suspension was supplemented with 0.1 mg/ml DNaseI and protease inhibitors 
[2 mM PMSF, 4 µg/ml pepstatin, 4 µg/ml leupeptin, 8 µg/ml aprotinin] and 
lysed by repeated passage through a high-pressure homogeniser (EmulsiFlex-
C3, Avestin). The lysates were cleared by centrifugation at 20,000 g for 60 
minutes. The supernatant was removed, supplemented with 0.5% (v/v) Triton 
X-100, and incubated for 60 minutes at 4˚C with glutathione sepharose beads 
(GE Healthcare; 0.5 ml per litre of bacterial culture). The beads were washed 
four times with 50 ml of TNGMT buffer (supplemented with 0.05% Triton X-
100) and incubated for 20 minutes with 2 bed volumes of TNTGsh buffer (50 
mM Tris pH 7.4, 150 mM NaCl, 40 mM GSH, 1mM TCEP). The slurry was 
passed through a table-top column and the flow-through was collected after a 
wash with 1 bed volume of TNTGsh elution buffer. Tobacco Etch Virus 
protease (TEV) was added (1:100 mol:mol) and the eluate was incubated 
overnight at 4˚C to remove the GST tag. The eluted and cleaved proteins were 
concentrated and passed through a Superdex 200 10/300 GL gel filtration 
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column (GE Healthcare) connected in series with a 1 ml GSTrap FF column 
(GE Healthcare) equilibrated in HKG buffer (50 mM HEPES-KOH pH 7.6, 150 
mM KCl, 10% glycerol). For IRE1LD-cys, the buffer was supplemented with 1 
mM TCEP and 0.1 mM EDTA. Appropriate fractions were collected, 
concentrated, and flash frozen. 
IRE1LD-cys (UK1915) and IRE1CLD-cys (UK1998) were labelled with a 3-fold 
molar excess of biotin-maleimide (Sigma) to make IRE1LD-biotin and IRE1CLD-
biotin, respectively. IRE1LD-cys was labelled with a 1:100 (mol:mol) ratio of 
Oregon Green-iodoacetic acid (ThermoFisher) to make IRE1LD-OG. The 
reaction proceeded at room temperature in the dark for two hours and was 
quenched by the addition of 5 mM DTT. The reaction mixture was passed 
through a CentiPure P10 gravity-desalting column (Generon) equilibrated in 
HKG buffer and through a Superdex 200 10/300 GL gel filtration column 
equilibrated in HKG buffer. Appropriate fractions were collected, concentrated, 
and flash frozen. 
The IRE1LD R234C (UK2048) and IRE1LD S112C (UK2076) used to make 
IRE1LD-donor and IRE1LD-acceptor, respectively, were encoded on a pET-
derived vector (Novagen) as a His-Smt3 fusion protein and expressed as 
described above. Cells were harvested in HNKIGT buffer (25 mM HEPES-
KOH pH 7.5, 400 mM NaCl, 100 mM KCl, 25 mM imidazole, 10% glycerol, 1 
mM TCEP) and lysed and clarified as above. The lysates were cleared by 
centrifugation at 20,000 g for 60 minutes. The supernatant was removed, 
supplemented with 0.5% (v/v) Triton X-100, and incubated for 60 minutes at 4˚ 
C with Ni-NTA Agarose beads (ThermoFisher; 0.75 ml per liter of bacterial 
culture). The beads were washed four times with 50 ml of HNKIGT buffer 
(supplemented with 0.05% Triton X-100) and eluted with HNKIGT buffer 
supplemented with 250 mM imidazole. The eluate was concentrated, passed 
through a gravity desalting column equilibrated with HKG supplemented with 1 
mM TCEP and 0.1 mM EDTA, concentrated and labelled overnight at room 
temperature with a 3-fold molar excess of TAM-maleimide (Sigma; S112C) or 
Oregon Green-iodoacetic acid (ThermoFisher; R234C). The reaction mixtures 
were quenched, passed through a gravity desalting column, and passed 
through an S200 column as described above and the appropriate fractions 
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were concentrated and flash frozen. IRE1CLD-S112C (UK2117) and IRE1CLD-
R234C (UK2118) were expressed, purified, and labelled similarly. 
The IRE1LD Q105C (UK2045) used to make disulfide-linked dimeric IRE1LD-bio 
was expressed as an His6-Smt3 fusion protein in Origami B(DE3) cells 
(Novagen) and purified without reducing agent as described above. Dimeric 
IRE1LD-Q105C and standard IRE1LD (UK2007) were labelled at a 1:10 (mol:mol) 
ratio with biotin-NHS ester (Sigma) for one hour at room temperature to create 
disulfide-linked dimeric IRE1LD-bio and wild-type IRE1LD-bio, respectively. 
Reactions were quenched by the addition of 5 mM Tris-HCl pH 8. 
Hamster ERdj4 
ERdj4 and variants were expressed as fusion proteins with an N-terminal 
His6-Smt3 (UK2012 for WT, UK2040 for QPD) or with both an N-terminal 
His6-Smt3 and C-terminal MBP (UK2108 for WT, UK2119 for QPD). Proteins 
were expressed in Origami B(DE3) cells. ERdj4 proteins expressed in BL21 
(DE3) cells were not soluble, suggesting that ERdj4 may have a stabilising 
disulfide between its two cysteines therefore, no reducing agent was used in 
purification of Erdj4 or its variants. Cells were grown and lysed as described 
above for His6-Smt3 tagged proteins. Media of cells expressing His6-Smt3-
ERdj4-AviTag (UK2098) was supplemented with 0.2 mM Biotin (to allow the 
endogenous biotinylation enzymes of the bacteria to biotinylate the Erdj4 
protein). The lysates were purified by Ni affinity chromatography as described 
above. His6-Smt3-ERdj4 was aliquoted immediately after elution from the Ni 
matrix. It was found to precipitate immediately upon cleavage of Smt3 by Ulp1. 
His6-Smt3-ERdj4-MBP was loaded onto an S200 10/300 GL column 
equilibrated in HKG buffer. Fractions containing His6-Smt3-ERdj4-MBP were 
collected, aliquotted, and flash-frozen.  
Human GRP170 
N-terminally His6-tagged human GRP170 (UK1264) was expressed in BL21 
(DE3) cells and induced, lysed, bound to a Ni-NTA agarose beads as 
described above however, no detergent was present in any of the buffers and 
all buffers contained 5 mM ATP. The beads were sequentially washed with 
two bed volumes of HNIGβA buffer (50 mM HEPES-KOH pH 7.4, 300 mM 
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NaCl, 5% glycerol, 10 mM imidazole, 5 mM β-mercaptoethanol, 5 mM ATP) 
supplemented with 0.5 M NaCl, 3 mM Mg2+-ATP, 0.25 M Tris pH 7.5, and 35 
mM imidazole. The protein was then eluted in buffer HNIGβA supplemented 
with 240 mM imidazole. The eluted protein was loaded onto an Superdex 
S200 10/300 GL column equilibrated in HKMA buffer (50 mM HEPES-KOH pH 
7.4, 150 mM KCl, 10 mM MgCl2, 0.5 mM ATP). GRP170-containing fractions 
were aliquotted and flash-frozen. 
BiP  
BiP and BiP variants were purified as previously described (Petrova et al., 
2008; Preissler et al., 2015a). Briefly, His6-BiP (WT and variants) was 
expressed and purified from BL21 C3013 E. coli cells as described above for 
His6-Smt3-IRE1. Cells were lysed in TNGMTr buffer (50 mM Tris pH 7.4, 500 
mM NaCl, 10% glycerol, 1 mM MgCl2, 0.2% (v/v) Triton X-100, 20 mM 
imidazole) containing protease inhibitors and DnaseI as above. Prior to elution 
of BiP from the Ni-NTA agarose beads, the beads were washed with TNGMTr 
sequentially supplemented with 30 mM imidazole, 1% (v/v) Triton X-100, 1 M 
NaCl, 5 mM Mg2+-ATP and 0.5 M Tris–HCl pH 7.5. BiP was eluted in TNGMIz 
buffer (50 mM Tris–HCl pH 7.5, 500 mM NaCl, 1 mM MgCl2, 10% (v/v) 
glycerol, 250 mM imidazole) and dialysed against HKM buffer (50 mM 
HEPES-KOH pH 7.4, 150 mM KCl, 10 mM MgCl2).  
BiP NBD was purified as described for His6-Smt3-IRE1. After elution the 
protein was concentrated and passed through a CentiPure gravity-desalting 
column into 50 mM HEPES pH 7.4, 150 mM KCl, 10% glycerol and 0.1 mM 
EDTA. 
AMPylation of purified BiP proteins was performed as previously described 
with minor modifications (Preissler et al., 2015a). Purified BiP was incubated 
for 6 hours at 30°C with 0.25 mg bacterially expressed FICDE234G per 20 mg of 
BiP protein in presence of 3 mM ATP in buffer I [25 mM HEPES-KOH pH 7.4, 
100 mM KCl, 10 mM MgCl2, 1 mM CaCl2, 0.1% (v/v) Triton X-100] followed by 
binding to Ni-NTA agarose beads for 1 hour at 25°C. The beads were washed 
with buffer I, and eluted in buffer I containing 350 mM imidazole for 45 minutes 
at 25°C. The eluate was desalted using a CentriPure column equilibrated in 




The J-domain of ERdj6 (UK185) was purified as previously described (Petrova 
et al., 2008). Briefly, the J-domain of ERdj6 was expressed as a GST fusion 
protein and purified as described above for GST fusion proteins. The protein 
was eluted in buffer H [50 mM HEPES-KOH pH 7.4, 100 mM KCl, 4 mM 
MgCl2, 1 mM CaCl2, 0.1% (v/v) Triton X-100, 1 mM DTT, 10% (v/v) glycerol, 
40 mM reduced glutathione] and dialysed over night against HKM buffer.  
 
GADD34-bio 
GADD34-bio (UK1920) was purified as previously described (Crespillo-
Casado et al., 2017). Briefly, GADD34-bio (PPP1R15A) was purified as above 
for GST tagged proteins with the modification that the TNGMT lysis buffer was 
supplemented with 1 mM MnCl2. Following the initial GST based purification 
and overnight incubation with TEV, cleaved GADD34 was bound to amylose 
beads (New England Biolabs) for 1–2 hr at 4°C. The amylose beads were 
washed with TNGMT and protein eluted with HEPES buffer (20 mM HEPES, 
100 mM NaCl, 0.2 mM CaCl2, 0.2 mM ATP, 0.2 mM TCEP, 0.5 mM MnCl2, 
100 µM PMSF, 20 mTIU/ ml aprotonin, 2 µM leupeptin, and 2 µg/ml pepstatin) 
and 10 mM maltose. The eluted GADD34 was then biotinylated using BirA 
(BirA UK1881 purified as described above for GST fusion proteins) in the 
presence of 2 mM MgCl2, 2 mM ATP, 0.01% Triton X-100, excess biotin (1:2 
molar ratio to substrate protein) and BirA (1/20th molar ratio of substrate 
protein). Following biotinylation GADD34-bio was passed through a CentiPure 
gravity-desalting column into HEPES buffer to remove excess of biotin that 
would interfere with the Bio-Layer Interferometry measurements. 
Streptavidin pull-down assays 
Assessing ERdj4 loading BiP onto IRE1 
Schema shown in figure 3.02. 20 µl Dynabeads MyOne Streptavidin C1 
(Thermo Fisher Scientific) per sample were used. Reactions were carried out 
in 150 mM KCl, 50 mM HEPES-KOH pH 7.4, 10 mM MgCl2, 1 mM CaCl2, 
0.1% Triton X-100. Reactions contained 5 µM IRE1LD-bio, 8 µM ERdj4 or 
variants, 30 µM BiP or variants, and 2 mM ATP. Reactions proceeded for 20 
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minutes at 30°C before quenching with an excess of ice cold 1 mM ADP and 
clarification at 21,130 g for 5 minutes, followed by the addition of magnetic 
beads to supernatant. Binding was carried out for 15 minutes before washes 
and elution in first 5 mM ATP followed by 1x SDS sample buffer. Pull-down 
experiments with the nucleotide binding domain of BiP were conducted 
similarly, but the ATP elution was skipped. 
Assessing ERdj4’s effect on IRE1 dimerisation 
Schema shown in figure 3.10. Beads were first preloaded with IRE1LD-bio and 
then washed extensively. Beads were then incubated with the reaction 
mixtures containing 0.5 µM IRE1LD-TAM with 8 µM ERdj4 or variants, 30 µM 
BiP or variants, and 2 mM ATP. Where indicated, reactions also contained 1 
µM GRP170. Reactions were quenched as described above. The beads were 
washed and the protein was eluted in SDS sample buffer. 
 
Assessing the disruption of IRE1 dimers 
Schema shown in figure 3.14. Beads were first pre-loaded with IRE1LD-bio and 
then washed extensively. Beads were incubated with 0.5 µM IRE1LD-TAM for 
one hour at 30˚ C, washed extensively, and then incubated with a solution of 
30 µM BiP, 8 µM ERdj4, 1 µM GRP170, and 2 mM ATP at 30˚C for 15 
minutes. The reaction was quenched as described above and the beads were 
washed and eluted in SDS sample buffer. 
Size-exclusion chromatography 
Sample were run through a SEC-3 300A, 4.6x300 mm column (Agilent 5190-
2513) on an Agilent infinity HPLC system. Samples were run in HKM buffer 
(150 mM KCl, 50 mM HEPES-KOH pH 7.4, 10 mM MgCl2). Reactions 
proceeded in 20 µl for 20 minutes at 30°C before clarification at 21,130 g for 5 
minutes and subsequent injection. 
Bio-Layer Interferometry experiments 
Experiments were performed on an Octet RED96 (Pall ForteBio). Experiments 
were performed in HKMGTr buffer (50 mM HEPES-KOH pH 7.6, 150 mM KCl, 
10 mM MgCl2, 10% glycerol, 0.05% Triton X-100). 
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In the sequential dipping experiment (Figure 3.11), streptavidin biosensors 
were loaded with IRE1LD-bio or GADD34-bio to approximately 1 nm shift, 
washed in buffer, and then sequentially dipped in wells containing 1.5 µM 
Smt3-ERdj4 or variants, 1 µM BiP with no nucleotide, 1µM BiPT229A with 2 mM 
ATP, 1 µM BiPV461F with 2 mM ATP, and 1 µM BiP. Data were decimated, 
background-subtracted, and normalised to the signal after the first wash step. 
In the titration experiment (Figure 3.12), streptavidin biosensors were loaded 
with Smt3-ERdj4-bio to approximately 1 nm shift, washed in buffer, and then 
dipped in wells containing the indicated concentration of IRE1LD. Data were 
decimated and normalised to the signal after the first wash step 
In the sequential dipping experiment (Figure 3.13), streptavidin biosensors 
were loaded with IRE1LD-bio to approximately 1 nm shift, washed in buffer, 
and then dipped in wells containing the indicated concentration of Smt3-
ERdj4. Data were decimated, background subtracted, and normalised to the 
signal after the first wash step. 
In the elution experiments (Figure 3.13), streptavidin biosensors were loaded 
with IRE1LD-bio to a shift of approximately 7.5 nm. The biosensors were 
washed in buffer and then dipped in wells containing 1.2 µM Smt3-ERdj4. The 
biosensors were washed in buffer and then dipped in wells containing either: 6 
µM BiP with no ATP, 6 µM BiP with 2 mM ATP, or 6 µM BiPV461F with 2 mM 
ATP. The biosensors were then washed in buffer with 2 mM ATP and the 
protein eluted in SDS sample buffer. 
 
In the sequential dipping and elution experiment (Figure 3.16), streptavidin 
biosensors were loaded with IRE1LD-bio (UK2007) or IRE1LD Q105C-bio 
(UK2045) to a shift of approximately 2.5 nm. The biosensors were washed in 
buffer and then dipped in wells containing 1.7 µM Smt3-ERdj4. The 
biosensors were washed in buffer and then dipped in wells containing: 6 µM 
BiP with 2 mM ATP, or just buffer. The biosensors were then washed in buffer 
with 2 mM ATP and the protein eluted in SDS sample buffer and ran on a non-
reducing SDS-PAGE gel. The BLI data was decimated and normalised to the 




FRET equilibrium experiments 
In figure 3.20 IRE1LD-donor and IRE1LD-acceptor were combined at a 1:2 ratio 
and incubated at room temperature in the dark for two hours. IRE1LD-
donor/acceptor (0.2 µM total) was combined with unlabelled IRE1LD at the 
specified concentration in HKMGTw buffer (50 mM HEPES-KOH pH 7.6, 150 
mM KCl, 10 mM MgCl2, 10% glycerol, 0.05% TWEEN 20) and incubated for 3 
hours. The samples were transferred to a black low volume 384-well plate and 
donor fluorescence was recorded with a CLARIOstar platereader (BMG), 
exciting at 470-15 nm and reading emission at 524-20 nm. Alternatively, 
IRE1LD-donor/acceptor was combined with BiP at the specified concentration 
in HKMGTw buffer and incubated for 24 hours. Fluorescence was recorded as 
described above. Fluorescence was normalised to that of IRE1LD-
donor/IRE1LD acceptor absent titrant. 
FRET kinetic experiments 
IRE1LD-donor and IRE1LD-acceptor were combined at a 1:2 ratio and 
incubated at room temperature in the dark for two hours. In figure 3.21-3.22 on 
a black low volume 384-well plate, BiP, Smt3-ERdj4-MBP, and IRE1LD-
donor/acceptor were combined in HKMGTw buffer. The concentrations used 
were 30 µM BiP variants, 2.5 µM ERdj4 variants, and 0.2 µM IRE1LD-
donor/acceptor. After incubation for 30 minutes, 2 mM ATP with an ATP 
regeneration system (8 mM phosphocreatine, 0.016 mg/ml creatine kinase) 
was added to initiate the reaction. In indicated wells, 1 µM GRP170 was 
added along with ATP and the regeneration system. In figure 3.23, 50 µM BiP, 
2.5 µM Smt3-ERdj4-MBP, and 0.2 µM equilibrated IRE1LD-donor/acceptor 
were combined in HKMGTw buffer. After incubation for 30 minutes, 2 mM ATP 
with the ATP regeneration system was added to initiate the reaction. At the 
indicated time, buffer, CH1 heptapeptide (HTFPAVL, a model BiP substrate) 
at the indicated concentration, and/or 2.5 µM ERdj6 J-domain was added. In 
all kinetic experiments, donor fluorescence was followed with a CLARIOstar 
plate reader (excitation: 470-15 nm / emission: 524-20 nm) recording 




Peptide binding anisotropy experiments 
FAM labelled and unlabelled MPZN (LIRYCWLRRQAA) peptides (as 
described in Karagöz et al., 2017 were purchased from Genscript. 
Anisotropy was measured using a CLARIOstar plate reader. Parallel and 
perpendicular fluorescence of the FAM fluorophore was measured using 
excitation at 496 nm and measuring emission at 519-550 nm. 
FAM-MPZN was kept at 100 nM in reactions. The concentrations of IRE1 
variants and unlabelled MPZN used are detailed in the figure legends. 
Components were mixed together in 25 µl and then 20 µl transferred to a 
black flat bottomed 384 well plate and incubated for 30 minutes prior to 
reading. Fluorescence readings were corrected by subtracting fluorescence 
from a well containing only buffer. The average of 6 readings (spaced at 30 s 
intervals) per well was taken as one repeat and the average of three 
independent repeats was used for the final data presented. 
Anisotropy is calculated as:   (Ipara – Iperp)/(Ipara + 2*Iperp) 
The data in figure 5.01 was fit to the equation rfree + (rmax – rfree)[X]h/([X]h+Kh) where 
rfree is the anisotropy in the absence of protein, rmax is the theoretical maximal 
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Appendix table 1 
ID Primer name Sequence Description 











Primer for Q105C repair template of Q105 region of CHO 
IRE1 
1100 IRE1_Q105_region_1s  AGCCTCCATCTGCAGTGTGCTTCTCTG Oligos for genotyping of CHO IRE1 Q105 region 
1101 IRE1_Q105_region_2as  
CACAACTTTCCCAGATTCCAGGATTC 
ACTGTC Oligos for genotyping of CHO IRE1 Q105 region 
1116 IRE1_Q105_region_3s  GCTAGAAATAGTGTGGAGTGATCAG 
Oligos for generating repair template of CHO IRE1 Q105 
region 
1117 IRE1_Q105_region_4as  AACTATTCCCAGGTCACAGGTTATA 





Oligo 1100 with 5'FAM for genotyping of CHO IRE1 Q105 
region 
1234 IRE1_11.1s_1s CACCGTTCCTGCTGATTCGGAAAAA Creating guide for targeting CHO IRE1 for screen I 
1235 IRE1_11.1s_2as AAACTTTTTCCGAATCAGCAGGAAC  Creating guide for targeting CHO IRE1 for screen I 
1236 IRE1_11.1as_1s CACCGATGCAGACAGAGGAGTTTCA Creating guide for targeting CHO IRE1 for screen I 
1237 IRE1_11.1as_2as AAACTGAAACTCCTCTGTCTGCATC Creating guide for targeting CHO IRE1 for screen I 
 
150 
1238 IRE1_11.2as_1s CACCGGGGGAATCTCTCCAGCATCT Creating guide for targeting CHO IRE1 for screen I 
1239 IRE1_11.2as_2as AAACAGATGCTGGAGAGATTCCCCC Creating guide for targeting CHO IRE1 for screen I 
1240 IRE1_11.3as_1s CACCGAATCACATTTTCCCGATGTT Creating guide for targeting CHO IRE1 for screen I 
1241 IRE1_11.3as_2as AAACAACATCGGGAAAATGTGATTC Creating guide for targeting CHO IRE1 for screen I 
1242 IRE1_12.1s_1s CACCGTCCATACAAGGTTATCAACA Creating guide for targeting CHO IRE1 for screen I 
1243 IRE1_12.1s_2as AAACTGTTGATAACCTTGTATGGAC Creating guide for targeting CHO IRE1 for screen I 
1244 IRE1_12.2s_1s CACCGTCAGGCCGTGGAAGAGAAGC Creating guide for targeting CHO IRE1 for screen I 
1245 IRE1_12.2s_2as AAACGCTTCTCTTCCACGGCCTGAC Creating guide for targeting CHO IRE1 for screen I 
1246 IRE1_12.3s_1s CACCGCCATGCCCCCGCCAAGCCTG Creating guide for targeting CHO IRE1 for screen I 
1247 IRE1_12.3s_2as AAACCAGGCTTGGCGGGGGCATGGC Creating guide for targeting CHO IRE1 for screen I 
1248 IRE1_12.1as_1s CACCGACGGCCTGAGACACAGTGGA Creating guide for targeting CHO IRE1 for screen I 
1249 IRE1_12.1as_2as AAACTCCACTGTGTCTCAGGCCGTC Creating guide for targeting CHO IRE1 for screen I 
1274 ERdj1_guide1_S  CACCGGGCCCCGGGCGCCGGCGCTG CRISPR-Cas9 guide oligonucleotide ERdj1 
1275 ERdj1_guide1_AS  AAACCAGCGCCGGCGCCCGGGGCCC CRISPR-Cas9 guide oligonucleotide ERdj1 
1276 ERdj1_guide2_S  CACCGGGCCGCTGTCGTCCTCCGTT CRISPR-Cas9 guide oligonucleotide ERdj1 
1277 ERdj1_guide2_AS  AAACAACGGAGGACGACAGCGGCCC CRISPR-Cas9 guide oligonucleotide ERdj1 
1278 ERdj2_guide1_S  CACCGTCCAAGTTTAATACTTCATA CRISPR-Cas9 guide oligonucleotide ERdj2 
1279 ERdj2_guide1_AS AAACTATGAAGTATTAAACTTGGAC CRISPR-Cas9 guide oligonucleotide ERdj2 
1280 ERdj3_guide1_S  CACCGGAAATCTCGCCTGAGAGGAC CRISPR-Cas9 guide oligonucleotide ERdj3 
1281 ERdj3_guide1_AS  AAACGTCCTCTCAGGCGAGATTTCC CRISPR-Cas9 guide oligonucleotide ERdj3 
 
151 
1282 ERdj3_guide2_S  CACCGGCCTCGGAGTGCCTCCGTAA CRISPR-Cas9 guide oligonucleotide ERdj3 
1283 ERdj3_guide2_AS  AAACTTACGGAGGCACTCCGAGGCC CRISPR-Cas9 guide oligonucleotide ERdj3 
1284 ERdj4_guide1_S  CACCGCTCAGAGCGACAAATCAAGA CRISPR-Cas9 guide oligonucleotide ERdj4 
1285 ERdj4_guide1_AS  AAACTCTTGATTTGTCGCTCTGAGC CRISPR-Cas9 guide oligonucleotide ERdj4 
1286 ERdj4_guide2_S  CACCGGATATCATAGTAGCTCTTTG CRISPR-Cas9 guide oligonucleotide ERdj4 
1287 ERdj4_guide2_AS  AAACCAAAGAGCTACTATGATATCC CRISPR-Cas9 guide oligonucleotide ERdj4 
1288 ERdj5_guide1_S CACCGCTTCAGTGCTAATTTCTTAA CRISPR-Cas9 guide oligonucleotide ERdj5 
1289 ERdj5_guide1_AS  AAACTTAAGAAATTAGCACTGAAGC CRISPR-Cas9 guide oligonucleotide ERdj5 
1290 ERdj5_guide2_S  CACCGTTCTCTACTACTTGCAGTTT CRISPR-Cas9 guide oligonucleotide ERdj5 
1291 ERdj5_guide2_AS  AAACAAACTGCAAGTAGTAGAGAAC CRISPR-Cas9 guide oligonucleotide ERdj5 
1292 ERdj6_guide1_S  CACCGGTGACTGTTTCAGTAACCGC CRISPR-Cas9 guide oligonucleotide ERdj6 
1293 ERdj6_guide1_AS  AAACGCGGTTACTGAAACAGTCACC CRISPR-Cas9 guide oligonucleotide ERdj6 
1294 ERdj6_guide2_S  CACCGCTAAACCTTCCCGAATCTGC CRISPR-Cas9 guide oligonucleotide ERdj6 
1295 ERdj6_guide2_AS  AAACGCAGATTCGGGAAGGTTTAGC CRISPR-Cas9 guide oligonucleotide ERdj6 
1296 ERdj7_guide1_S  CACCGGAAAGATTATGACTACATGC CRISPR-Cas9 guide oligonucleotide ERdj7 
1297 ERdj7_guide1_AS  AAACGCATGTAGTCATAATCTTTCC CRISPR-Cas9 guide oligonucleotide ERdj7 
1298 ERdj7_guide2_S  CACCGACCACCCTAACATCCACTTT CRISPR-Cas9 guide oligonucleotide ERdj7 
1299 ERdj7_guide2_AS  AAACAAAGTGGATGTTAGGGTGGTC CRISPR-Cas9 guide oligonucleotide ERdj7 
1367 ERdj1_genomic_S  CCGGCGCGCTTACCTGC Oligo for genotyping indels  
1368 ERdj1_genomic_AS  CTCGGAACCCAGTGCGATGTG Oligo for genotyping indels  
 
152 
1369 ERdj2_genomic_S  
GCCATACAGTTGAATTTATTTAT 
GTCATTTGTC Oligo for genotyping indels  
1370 ERdj2_genomic_AS  
GTTAACAGTTCAAATTCTGATTT 
CTTTTGGAAATGTC Oligo for genotyping indels  
1371 ERdj3_genomic_S  AGTGGGGACTGTGAGAGAAGG Oligo for genotyping indels  
1372 ERdj3_genomic_AS  AATTTCTCCTGGGCTTGGGGATCG Oligo for genotyping indels  
1373 ERdj4_genomic_S  GTGCATAGCTTTTCGAATGCTGC Oligo for genotyping indels  
1374 ERdj4_genomic_AS  CTTCAGCATCAGGGCTCTTATTTTTG Oligo for genotyping indels  
1375 ERdj5_genomic_S  
GTATCTTAATGTCACTTAAATAAGAA 
CTTGC Oligo for genotyping indels  
1376 ERdj5_genomic_AS  
CCAGATATTTAAAAGAGAAATTTTAC 
CTACC Oligo for genotyping indels  
1377 ERdj6_genomic_S  CATTCAGGATTATGAAGCTGCTCAGG Oligo for genotyping indels  
1378 ERdj6_genomic_AS  ACGCTAAGGGCTCTCAGAATAACG Oligo for genotyping indels  
1379 ERdj7_genomic_S  TACGTGCCTTTAAGAGTATTGGGAAG Oligo for genotyping indels  
1380 ERdj7_genomic_AS  CACTGAAATGGCACATACACTGACC Oligo for genotyping indels  
1391 ERdj1_genomic_2_S  ATGTGGGCTCCCGGCTTCGGAC Oligo for genotyping indels  










6FAM] AGTGGGGACTGTGAGAGAAGG Oligo for genotyping indels (FAM)  
1395 
ERdj4_genomic_S [5'-





AACTTGC Oligo for genotyping indels (FAM)  
1397 
ERdj6_genomic_S [5'-
6FAM] CATTCAGGATTATGAAGCTGCTCAGG Oligo for genotyping indels (FAM)  
1398 
ERdj7_genomic_S [5'-
6FAM] TACGTGCCTTTAAGAGTATTGGGAAG Oligo for genotyping indels (FAM)  
1409 
ERdj1_genomic_2_AS 
[5'-6FAM] TTACCTGCTGCACCCCGAGGAACTC Oligo for genotyping indels (FAM)  
1470 hamXBP1.19S GGCCTTGTAATTGAGAACCAGGAG For XBP1 Reverse transcription PCR assay 
1618 ERdj8_guide1_S  CACCGAGGCATATAAGAAGCTCGCC CRISPR guide targeting Ch ERdj8 (Dnajc16) 
1619 ERdj8_guide1_AS  AAACGGCGAGCTTCTTATATGCCTC CRISPR guide targeting Ch ERdj8 (Dnajc16) 
1650 ERdj8_genomic_1_S gagagATGgaggtgaaaaagctgagcgtctc genotyping ERdj8 KOs in CHO cells 
1651 ERdj8_genomic_1_AS 
ATCATAATTCAGGCTTCAGGC 
ACCTGCCTACTGC genotyping ERdj8 KOs in CHO cells 
1652 ERdj8_genomic_2_S  cagaaggaagagagATGgaggtgaaaaagctg genotyping ERdj8 KOs in CHO cells 





CAATACTC Oligo for genotyping indels (FAM)  
 
154 
2149 IRE1_10.1s_1s CACCGGTGTCACCATTGAAGACAA Creating guide for targeting CHO IRE1 for screen II 
2150 IRE1_10.1s_2as AAACTTGTCTTCAATGGTGACACC Creating guide for targeting CHO IRE1 for screen II 
2151 IRE1_10.2s_1s CACCGAGTTTGACCCTGGACTCAAA Creating guide for targeting CHO IRE1 for screen II 
2152 IRE1_10.2s_2as AAACTTTGAGTCCAGGGTCAAACTC Creating guide for targeting CHO IRE1 for screen II 
2153 IRE1_10.3s_1s CACCGAGAGCAAGCTGAACTACTTG Creating guide for targeting CHO IRE1 for screen II 
2154 IRE1_10.3s_2as AAACCAAGTAGTTCAGCTTGCTCTC Creating guide for targeting CHO IRE1 for screen II 
2155 IRE1_10.1as_1s CACCGTGCTCTTCCCTTTGAGTCCA Creating guide for targeting CHO IRE1 for screen II 
2156 IRE1_10.1as_2as AAACTGGACTCAAAGGGAAGAGCAC Creating guide for targeting CHO IRE1 for screen II 
2157 IRE1_10.2as_1s CACCGAAACTTGAGGTCTGTGCTGG Creating guide for targeting CHO IRE1 for screen II 
2158 IRE1_10.2as_2as AAACCCAGCACAGACCTCAAGTTTC Creating guide for targeting CHO IRE1 for screen II 
2159 IRE1_10.3as_1s CACCGACACTCTCCTTTGTCTTCAA Creating guide for targeting CHO IRE1 for screen II 
2160 IRE1_10.3as_2as AAACTTGAAGACAAAGGAGAGTGTC Creating guide for targeting CHO IRE1 for screen II 
2161 IRE1_10.4as_1s CACCGATGGTGACACCATCTGTCTG Creating guide for targeting CHO IRE1 for screen II 
2162 IRE1_10.4as_2as AAACCAGACAGATGGTGTCACCATC Creating guide for targeting CHO IRE1 for screen II 
2163 IRE1_10.5as_1s CACCGTCTGGGGACCTTCCAGCAA Creating guide for targeting CHO IRE1 for screen II 
2164 IRE1_10.5as_2as AAACTTGCTGGAAGGTCCCCAGAC Creating guide for targeting CHO IRE1 for screen II 
2165 IRE1_10.6as_1s CACCGCAAAGGAAGAGTGCTTCCT Creating guide for targeting CHO IRE1 for screen II 
2166 IRE1_10.6as_2as AAACAGGAAGCACTCTTCCTTTGC Creating guide for targeting CHO IRE1 for screen II 
Appendix table 2 
ID Plasmid name Description 
1047 PERK_GST_pCDNA3 mPERK 1-585 (LD + TM) fused to GST 
1070 pFLAGM1_mP58dSP1_CMV1 FLAGM1 mP58 27_504 (∆SP) in pFLAG_pCMV1 
1314 pCEFL_mCherry_3XFLAG_C pCEFL with 3XFLAG_C tagged from mCherry-tagged plasmid 
1558 IRE1_Q105C_g1b_pSpCas9(BB)-2A-Puro Cas9 targetted to CHO IRE1 exon 5 to introduce indel 
1559 IRE1_Q105C_g2a_pSpCas9(BB)-2A-Puro Cas9 targetted to CHO IRE1 exon 5 to introduce Q105C via HDR 
1610 pSpCas9(BB)-2A-mCherry_V2 
pSpCas9(BB)-2A vector to express mCherry together with guide 
RNA/Cas9 
1624 CHO_IRE1_guide11.1s_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1625 CHO_IRE1_guide11.1as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1626 CHO_IRE1_guide11.2as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1627 CHO_IRE1_guide11.3as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1628 CHO_IRE1_guide12.1s_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1629 CHO_IRE1_guide12.2s_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1630 CHO_IRE1_guide12.3s_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1631 CHO_IRE1_guide12.1as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen I 
1682 ERdj1_g1_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj1 
1683 ERdj1_g2_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj1 
1684 ERdj2_g1_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj2  
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1685 ERdj3_g1_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj3  
1686 ERdj3_g2_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj3  
1687 ERdj4_g1_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj4  
1688 ERdj4_g2_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj4 
1689 ERdj5_g1_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj5 
1690 ERdj5_g2_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj5  
1691 ERdj6_g1_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj6 
1692 ERdj6_g2_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj6  
1693 ERdj7_g1_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj7 
1694 ERdj7_g2_pSpCas9(BB)-2A-mCherry mCherry-tagged CRISPR plasmid (UK1610) for hamster ERdj7 
1703 hIRE1α_19-486_dC_GST_del3UTR _pCDNA3 GST-hIRE1α lacking luminal cysteines for mammalian expression 
173 haBiP_27-654_pQE10 N-terminally His6-tagged hamster BiP 
1739 pCEFL_mCherry_CHO_ERdj4_3XFLAG_C  3xFLAG-ERdj4 in mCherry vector for mammalian expression 




GST-Δ403-411-hIRE1α lacking luminal cysteines for mammalian 
expression 
182 haBiP_27-654_V461F_pQE10 N-terminally His6-tagged hamster BiP V461F 




GST--Q105C-hIRE1α lacking luminal cysteines for mammalian 
expression 
1881 EcBirA_WT_pGEX_TEV Bacterial expression of fastidious E. coli BirA biotin ligase (R118 intact) 
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1915 pGEX_GST_TEV_hIRE1a_LD∆C_24-442_D443C N-GST- cysteine free human Ire1LD 24-442 with a C-terminal cysteine 
1920 huPPP1R15A_533_624_malE_pGEX_TEV_AviTag N-tern AviTagged human GADD34 533–624 
1968 CHO_IRE1_hIRE1-LD_reptemp4_pCR-Blunt2-TOPO Repair template for WT hIRE1 LD reconstitution in CHO cells 
2007 pGEX_GST_TEV_hIRE1a_LD∆C_24-443 N-terminally GST-tagged cysteine free human Ire1LD 24-442 
2008 haBiP_27-405_NBD_pQE10  Bacterial expression of BiP NBD 
2012 Smt3_cgERdJ4_24-222_pET-21a N-terminally His6-Smt3-tagged chinese hamster ERdj4 24-222 
2016 
CHO_IRE1_hIRE1-LD(V437R)_reptemp4_pCR-
Blunt2-TOPO Repair template for V437R hIRE1 LD reconstitution in CHO cells 
2017 
CHO_IRE1_hIRE1-LD(L441R)_reptemp4_pCR-
Blunt2-TOPO Repair template forL441R hIRE1 LD reconstitution in CHO cells 
2018 CHO_IRE1_hIRE1-LD_rVdel_pCR Repair template for Δ403-411 hIRE1 LD reconstitution in CHO cells 
2019 CHO_IRE1_hIRE1-LD_rVtoglyser_pCR 
Repair template for hIRE1 LD with 403-441 hydrophobic residues 
mutated to Gly/Ser  
2036 CHO_hIRE1-LD_predhel2_SerSer_pCR 
Repair template for F400S, V403S, I404S, L406S hIRE1 LD 
reconstitution in CHO cells 
2040 Smt3_QPD_cgERdJ4_24-222_pET-21a N-terminally His6-Smt3-tagged chinese hamster ERdj4 24-222, H54Q 
2041 Smt3_J4_domain_24-90_pET-21a N-terminally His6-Smt3-tagged chinese hamster ERdj4 24-90 
2045 pET22b_H7_Smt3_Ire1a_LD∆C_24_443 Q105C 
N-terminally His6-Smt3-tagged cysteine free human Ire1LD 24-443, 
Q105C 
2047 pET22b_H7_Smt3_Ire1a_LD∆C_24_443 S152C Bacterial expression of Smt3-tagged cysteine-free Ire1a LD∆C S152C 
2048 pET22b_H7_Smt3_Ire1a_LD∆C_24_443 R234C N- His6-Smt3-tagged cysteine free human Ire1LD 24-443, R234C 
2076 pET22b_H7_Smt3_Ire1a_LD∆C_24_443 S112C N-terminally His6-Smt3-tagged cysteine free h Ire1LD 24-443, S112C 
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2080 pCMV1_SP_J4_mCherry_KDEL  mammalian expression CHO ERdj4 J domain alone mCherry + KDEL 
2098 Smt3_cgERdJ4_24-222_AviTag_pET21a N-His6-Smt3-ERdj4-Avi chinese hamster residues 24-222, H54Q 
2108 Smt3_cgERdJ4_24-222_GS6_MalE_pET21a N-His6-Smt3-ERdj4-MBP chinese hamster residues 24-222 
2117 pET22b_H7_Smt3_Ire1a_LD∆C_24_390 R234C N-His6-Smt3-tagged cysteine free human Ire1CLD 24-390, R234C 
2118 pET22b_H7_Smt3_Ire1a_LD∆C_24_390 S112C N-His6-Smt3-tagged cysteine free human Ire1CLD 24-390, S112C 
2119 Smt3_cgERdJ4_24-222_QPD_GS6_MalE_pET21a N-His6-Smt3-ERdj4-MBP chinese hamster residues 24-222 H54Q 
2127 pCMV1_SP_ERdJ4_3xFLAG_mCherry_KDEL mammalian expression CHO ERdj4 3xFLAG mCherry with KDEL 
2132 pCMV1_SP_QPD_J4_mCherry_KDEL mammalian expression CHO QPD J4 mCherry with KDEL 
2247 CHO_IRE1_guide10.1s_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2248 CHO_IRE1_guide10.2s_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2249 CHO_IRE1_guide10.3s_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2250 CHO_IRE1_guide10.1as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2251 CHO_IRE1_guide10.2as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2252 CHO_IRE1_guide10.3as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2253 CHO_IRE1_guide10.4as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2254 CHO_IRE1_guide10.5as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
2255 CHO_IRE1_guide10.6as_pSpCas9(BB)-2A-Cherry Cas9 and guide for targeting CHO IRE1 for screen II 
838 haBiP_27-654_T229A_pQE10 N-terminally His6-tagged hamster BiP T229A 
888 pFLAG_mCherry_KDEL_CMV1 mammalian expression of SP-FLAGM1-mCherry-KDEL (ER localized) 
Appendix table 3 
Gene Clone Allele 
Amino acid sequence (number shows amino acid 
position at which insert/deletion occured) 















#16 1 ...YNPY83inGSIKLGSWSNSSRN* 
  
2 ...QEYN81indelP* 




#11 1 …RSAS37inDFELQESYCAAMNDSINLVFYIPSILDLGTKTRXLNTYKGHQKGLQETSPTASS* 
  
2 ...VPRS35delAGN* 






#21 1 ...LASK25inRATMIS* 




#11 1 …RQAF55indelITIIKWTFL* 
  
2 …RQAF55inKEISTEVTS* 




#4 1 ...QIRE366delGTETVTETRLL* 
  
2 …EKAQ372inRVTETVTETRLL* 




#25 1 …LAPK23inGATALRPPSAPEWMLGW* 
  
2 …RLAP22delSGC* 








#41 1 ...YKKL52insYGRAYHLAPVLQ* 
  
2 …IKKA48del* 









CV8 1 …KLPFTIPELVCASPSRSSDGILYM… 
  
2 …KLPFTIPELVCASPSRSSDGILYM… 
IRE1 A2 cDNA FEE|::|KDMATIILS 
IRE1 B4 cDNA FEEVINLVDQTSENAPTTVSRDVEE|::|KDMATIILS 
IRE1 C13 cDNA FEE|QLLR|KDMATIILS 
IRE1 D23 cDNA FEE|PCI|KDMATIILS 





































































Appendix table 5 
 
Figure Original finding by: Data for figure from: 
2.02-2.03 M. Kamphuis M. Kamphuis 
2.23 N. Amin-Wetzel H. Harding 
3.05 N. Amin-Wetzel R. Saunders 
3.11-3.13 R. Saunders R. Saunders 
3.20-3.23 R. Saunders R. Saunders 
4.07 N. Kono N. Amin-Wetzel 
 
 
